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ABSTRACT 
 
Maternal nutrient restriction (MNR) in guinea pigs results in placental structural abnormalities 
that reduce nutrient transport contributing to fetal growth restriction (FGR). However, whether 
fetal oxygenation is also reduced as a further mediator of altered growth and development 
remains unknown. Guinea pig sows were fed ad libitum (Controls) or 70% of the control diet 
pre-pregnant switching to 90% at mid-pregnancy (MNR). Animals were necropsied near term for 
fetal-placental growth measures, blood metabolites, and markers of tissue hypoxia and oxidative 
stress. MNR resulted in FGR with brains that are large and livers that are small relative to body 
weight which suggests a degree of blood flow redistribution. FGR-MNR fetuses showed 
increased levels of hypoxia related markers in a tissue and sex specific manner, and decreased 
makers of oxidative stress. Together these results implicate hypoxia as a mechanism for aberrant 
growth and development and evidence for protective adaptations with MNR induced FGR. 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Maternal Nutrient Restriction (MNR), Fetal Growth Restriction (FGR), Hypoxia, 
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LITERATURE REVIEW  
2 
 
1.1 CLINICAL RELEVANCE   
1.1.1 Incidence and Classification of FGR 
The restriction of growth throughout pregnancy is an area of continuing research interests. This 
research is aimed at understanding both the etiology of growth restriction and its continued 
impact on health and disease. Fetal growth restriction (FGR), also known as intrauterine growth 
restriction (IUGR), and formally fetal growth retardation, is defined clinically and academically 
as having a weight below the 10th, 5th, or 3rd percentile for a given gestational age. However, 
not all fetuses that are small for their gestational age (SGA) are pathologically growth restricted 
and rather are constitutionally small. In Canada, in keeping with the World Health Organization 
guidelines, FGR is below the 10th percentile for gestation age and less than 2500 gms at term 
(Kramer 2003; Lackman 2001; Pollack 1992). FGR pregnancies have up to 6x higher fetal 
mortality. In addition, FGR severity is correlated with 5-30x higher neonatal mortality (Seeds 
1998; Piper 1996), along with increased neonatal morbidity (Bernstein 2000; Kramer 1990).   
Approximately 70% of fetuses with a birthweight below the 10th percentile are considered 
constitutionally small, with the remaining 30% having a pathologic origin for FGR. Due to this 
discrepancy, these definitions are not always reliable for being able to distinguish genuine FGR 
as a failure to obtain proper growth in utero from a fetus that is inherently small. Unfortunately, 
this distinction is often made by clinicians in retrospect after the infant is born, after a medical 
examination has been performed. This discrimination is very important as misdiagnosed small 
and healthy babies as FGR will generalize the definition, prevalence and resources of FGR.  
These indistinct definitions of FGR have resulted in other measures of fetal growth to be used in 
conjunction with fetal growth curves and percentile charts. Ponderal Index (PI) is the ratio of 
weight-to-height3 and is positively correlated with fetal leanness and nutritional status at term 
(Brandi 2003). Additionally, a decrease in the weight to length ratio at birth is ofeten used as a 
measure of fetal leanness and improper growth. A study from London, Ontario found placental 
weight to have a positive relationship with birth weight, but other studies have suggested that it 
is the functionality, not the overall size, that is impaired in the placenta with FGR and is another 
important indicator (Lackman 2001; Pollack 1992). This has led other studies to suggest that 
placental weight as a ratio for fetal weight will increase with the degree of FGR. Understanding 
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markers for fetal and placental size and shape is useful as predicators for the health of the fetus 
and postnatal outcome. 
 
1.1.2 Symmetrical vs. Asymmetrical Growth  
FGR phenotypically is classified as either symmetrical (sFGR) or asymmetrical (aFGR) growth 
restriction, based primarily on body proportion. The sFGR fetus implies that the entire body has 
undergone proportional restriction, and equally affects all growing parameters. This results in 
reduced growth measurements in early developing fetuses, thereby limiting brain growth 
proportionally to reductions in weight. Additionally, the sFGR will present with decreases in 
length and head circumference, but will have a normal ponderal index at birth (al Riyami 2011). 
The majority of growth restricted infants have asymmetric inhibition of growth. First, there is a 
restriction of weight, and then length, with a relative “head sparing” or “brain sparing” effect. 
The aFGR will present with normal head dimensions but small abdominal circumference (due to 
decreased liver size), scrawny limbs (due to decreased muscle mass) and a low ponderal index 
(due to increased leanness reflective of a disproportioned body) (al Riyami 2011; Halliday 2009; 
Campbell 1997; Lafeber 1984). This asymmetry in growth is more commonly due to extrinsic 
late-onsetting restriction in the latter half of gestation, which usually occurs in a more severe 
fashion, and gives rise to extreme concern to the developmental potential and health outcome of 
the fetus. Unlike aFGR, sFGR can be difficult to distinguish from inherently small fetuses 
because they are proportionally similar, but extreme deviation from a growth curve infers 
pathological sFGR. Previous studies have also distinguished between sFGR and aFGR in utero 
using a variety of ultrasound measurements. (Cambell 1977, al Riyami 2011), nevertheless the 
most reliable method for discriminating the two varieties is the brain-to-liver weight ratio; with 
aFGR disproportional with a decrease in liver weight, but a relatively normal or less decreased 
head and brain size, while sFGR presents with small livers and brains but correspondingly 
similar to appropriate for gestational age (AGA) fetuses (Cox 2009). Accordingly, brain-to-liver 
weight ratio is the preferred and popular method in animal studies of growth restriction to 
accurately identify aFGR at necropsy, where in the clinical setting head-to-abdominal 
circumference is used to determine aFGR in newborn or human fetus.  
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Asymmetrical fetal growth restriction is the more common variety, and is reported to occur in 
70% of growth restricted fetuses (Campbell 1977), although socioeconomic differences have 
been identified. Studies have reported that aFGR incidence is 60-80% of growth restricted babies 
in developed countries whereas symmetrical growth occurs more frequently in developing 
countries constituting 70-80%. This indicates that the causes of FGR, both asymmetrical and 
symmetrical, comes not from a single anatomical dysfunction or inhibition, and has led many 
researches to examine the exact combination of conditions that can contribute partially or 
sufficiently to incomplete fetal growth.   
 
1.1.3 Etiology of FGR 
Fetal growth does not rely on any one aspect, but rather is dependent on maternal, placental and 
genetic factors. Optimal growth is obtained by a balance of the genetic growth potential of the 
fetus, the efficiency of the placenta in transporting nutrients and oxygen and the state of the 
material environment.  These maternal-placental-fetal factors work in unison to provide an 
optimal envinroment for the fetus throughout gestation while supporting the physiological 
changes occurring in the mother. When one or more of these factors becomes dysfunctional, a 
sub-optimal intrauterine environment is created, and the fetus is unable to sustain normal growth 
and development. Fetal causes are the rarest and include genetic and chromosomal abnormalities 
and intrauterine infections, and usually have poor long-term prognosis (Cetin 2004; Han 1993; 
Pollack 1992). Maternal causes can arise before pregnancy; such as weight, age and parity, or 
during gestation; which include malnutrition, hypertension, and hypoxic conditions.  
Environmental conditions such as alcohol and drug use (Feng 2005; Pollack 1992) have also 
been reported to give rise to growth restriction. Placental factors that can contribute to sub-
optimal growth and development include abnormal cord insertions, placenta previa, placental 
infarcts, multiple gestations, and abruption placentae (Pollack 1992). Although any one of these 
factors can cause FGR, it is estimated that 60% of FGR is idiopathic deriving from a 
combination of factors, the majority of which involve some form of abnormal or aberrant 
placental development, commonly referred to as placental insufficiency (Ghidini 1996; Pallotto 
2006; Pollack 1992).  
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1.1.4 Placental Insufficiency 
The human placenta is the organ responsible for nutrient transfer between maternal and fetal 
tissues throughout gestation. Due to an increase in feto-placental blood vessels around 21 days 
gestation, nutrient transfer increases, turning an initially hypoxic in utero environment to one 
that is optimal for fetal growth and organ system development during the latter half of pregnancy 
(Kingdom 2000).  This growth and development is achieved by a 10-fold increase in the volume 
of the vasculature, an increase in the surface area of the placental labyrinth and a decrease in 
trophoblast thickness, all changes that promote nutrient exchange from maternal to the fetus 
(Myatt 2006). This transfer of includes nutrients, essential substrates, and oxygen required for 
proper growth and development.  
As mentioned, the majority of conditions affecting fetal growth are placental in origin. The most 
common placental conditions are abnormal alterations in the uteroplacental and fetal-placental 
circulations. In the majority of these cases, there is diminished maternal uteroplacental blood 
flow, caused by insufficient or incomplete trophoblastic invasion of the spiral arteries in the 
placental bed (Salafia 2006). Placental insufficiency is a general term used to describe any 
condition whereby the placenta is unable to transfer an appropriate amount of nutrients or 
oxygen for ultimate fetal growth. As mentioned earlier, this placental dysfunction can arise from 
numerous different aberrant structural or developmental changes during placentation (Kingdom 
2000). These alterations may result in poor fetal development and therefore FGR due to 
inadequate blood flow and thereby inefficient oxygenation, glucose and amino acid transport to 
the fetus (Jansson 1990; Mahendran 1993; Jones 1983; Myatt 2006). Under these conditions, the 
fetus adapts by altering metabolic and developmental processes at the expense of appropriate 
growth.  
1.1.5 FGR and long-term health 
Fetal growth restriction is the most common factor in stillborn births (Cosmi 2011). Furthermore, 
a number of causes of FGR have been associated with an increased risk of FGR and intrauterine 
death in a mother’s subsequent pregnancy (Cox 2009). Behind preterm birth, FGR is the second 
most common condition in newborns arising from pregnancy complications. Studies have 
suggested that the risk for spontaneous preterm delivery is increased for FGR fetuses and that 
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FGR contributed to a 5-6 fold increase in risk for perinatal morbidity (Lackman 2001). Along 
with morbidity among premature neonates, FGR is associated with a variety of long-term 
adverse health outcomes, with a risk of hypoxic brain injury; chronic lung disease; retinopathy of 
prematurity; tissue hypoxia; hypoglycemia; and mortality (Jang 2011; Rodriguez 2011 Feng 
2005).  Sex differences have been studied in incidences of FGR, although scantly, and it has 
been reported that females tend to be better protected and have a more favourable chance of 
surviving complications due to FGR compared to males (Synnes 2010). In a study from China, 
the incidence of FGR in females was significantly higher than in males, suggesting a female 
predilection for adaptation to a sub-optimal intrauterine environment relative to male 
counterparts (Liu 2014).  
Modern obstetric care has now targeted early gestation as a critical time point to intervene and 
attempt to rescue adverse outcomes and promote fetal growth and survival.  Mothers will often 
receive glucocorticoids treatment if there is a risk of delivering preterm with FGR, in an attempt 
to match the endogenous glucocorticoid burst prenatally that is essential for brain and lung 
development. Catch-up growth is a phenomenon that has also been studied in cases of FGR, 
where there is rapid growth after birth to match the growth curves of AGA babies . It has been 
reporeted that aFGR infants catch up in size within 3 years, while interestingly; sFGR newborns 
actually have a decreased rate of growth and weight gain for the first 38-40 weeks, followed by 
an increased weight gain rate (Strauss 1997). Strauss also demonstrated how 70% of  sFGR 
babies reached greater than the 10th  percentile by four months, they remained at a lower weight 
compared to AGA babies up to 3 years old (Strauss 1997). These growth trajectories, along with 
the myriad of complications and disorders that arise later in life due to FGR, suggest that 
intrauterine insults have a lasting impact on the health throughout pregnancy and into adulthood. 
 
1.1.6 Developmental Programming 
Fetal programming is the theory that organ development during times of sub-optimal substrate 
transfer is altered through adaptations by the fetus, which then predisposes the outcomes for 
health in later life (Barker 1998). This became known has the “developmental origins of adult 
disease” (DOHaD) hypothesis or the “Barker” hypothesis. These adaptations can permanently 
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change the structure and function of many of the body’s systems, and can be cardiovascular, 
metabolic, or endocrine in nature.  Fetal programming can occur in three different ways; 1) direct 
damage, such as early loss of a limb; 2) induction, deletion, or impaired development of structure 
resulting from insult during a critical period of development; or 3) physiological re-setting by an 
early stimulus or insult at a critical period with long term consequences for endocrine axes 
(Lucas 1994). These critical periods, as Barker and his colleges described, most likely occur in 
the fetus during phases of rapid cell division, and are usually influenced by the intrauterine 
environment rather than by genetics (Cosmi 2011). Low birth weight was the most common 
cause of infant death at the start of the 20th century, and these observations led to the hypothesis 
that low-birth-weight babies who survived infancy and childhood might be at increased risk of 
coronary heart disease in later life (Barker 2002; Boo 2006). Low birth weight, caused by either 
growth restriction or preterm birth, has more recently been associated with increased rates of 
cardiovascular disease and type-2 diabetes in adult life (Langley-Evans 2009). Therefore, the 
theory of DOHaD focuses on intrauterine life offers a novel approach to research investigating 
the long-term outcomes of a sub-optimal intrauterine environment, and the consequences of a 
fetus that has not matched its full growth potential during pregnancy.  Growing evidence has 
supported the idea that developmental adaptations made in utero, may lead to permanent changes 
or “programming” of the body (Barker 1998). To help characterize this phenomenon, Hales and 
Barker put forth the “Thrifty phenotype”. They proposed that the in utero environment provides 
cues of the postnatal environment for the fetus, which causes the fetus to make thrifty 
adaptations for survival. However, these once advantageous changes become detrimental if the 
postnatal environment differs from the cues established in utero (Hales 2001). Since the 
conception of DOHaD, a wide range of adverse intrauterine environments including alterations 
in oxygenation and hormone levels have been linked to increased incidence of cardiovascular 
and metabolic disease in adult life (Barker 1999). 
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1.2 CLINICAL STUDIES OF FGR AND FETAL PROGRAMMING 
1.2.1 Clinical Studies of Maternal Nutrition  
The most common cause of FGR arising from a maternal insult is malnutrition. Clinical study of 
maternal undernourishment and the impact on fetal development and adult health is complex, 
with many compounding factors. However, some studies suggest the impact of sub-optimal 
maternal nutrition on birth weight and developmental consequences. Early evidence of DOHaD 
in humans was observed during the Dutch famine, an acute period of exposure to suboptimal 
nutrition between 1944-1946 in The Netherlands. This cohort has been extensively studied, and 
reports show an increase in placental weight, but not in birthweight, in infants whose mothers' 
nutrition was compromised around conception or in the first trimester of pregnancy (Lumey 
1998). The increase in placental weight may represent a compensatory response for the reduction 
in substrate availability, as noted in medical evaluations of human FGR cases (Lumey 1998). 
Additionally, these children exposed to malnutrition in utero experienced decreased glucose 
tolerance in later life (Ravelli 1998) as further evidence for fetal programming. Similar studies in 
England found that low birth weight arising from maternal undernourishment was associated 
with increased mortality from cardiovascular and metabolic disease in later life (Barker 1993a; 
Barker 1993b).  
Maternal undernutrition is the most prominent contributor to FGR in developing countries, and it 
is estimated that over 200 million children and 11% of  current births in these countries fail to 
reach their full growth potential due to nutritional, social and health factors arising from poverty 
(Walker 2007; de Onis 1998). These studies in developing countries have linked low birth 
weight induced by poor nutrition to increases in cognitive impairment, depression, and 
behavioural problems in children up to three years of age, which primarily remain throughout 
adulthood compared to normal birth weight groups (Strauss 2000; Walker 2004; Villar 1984; 
Gardner 2003). It has also been found that food supplementation throughout pregnancy 
benefitted child motor development at 8 months but not 5 years, and food supplementation given 
only during the last trimester and throughout infancy did not benefit development from 6 months 
to 3 years (Adair 1981; Waber 2002). 
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From the above studies, it appears that the placenta functions as a nutrient sensor regulating 
nutrient transport according to the ability of the maternal supply line to deliver nutrients. By 
directly regulating fetal nutrient supply and fetal growth during gestation, the placenta plays a 
central role in fetal programming and low birth weight FGR (Jansson 2007). Furthermore, it 
appears that the placenta is “set” early during pregnancy based on the maternal nutritional supply 
and cannot easily be rescued by supplementation later on in pregnancy. It has also been reported 
that perturbations in the maternal compartment may affect the methylation status of placental 
genes and increase placental oxidative stress, resulting in changes in placental function (Jansson 
2007). Overall, maternal undernutrition plays a very important role in fetal programming and 
development, perhaps second only to placental insufficiency arising from placental 
complications during pregnancy, and constitutes a chronic insult on the mother, placenta and 
fetus. 
 
1.2.2 Chronic Hypoxia and Oxygen Homeostasis  
The mammalian body has many adaptive responses to both acute and chronic decreases in 
oxygen availability. Oxygen homeostasis is of the upmost importance, not only for proper 
development during pregnancy, but a continuous supply is necessary for survival. Fluctuating 
oxygen supply and demand cause premature reactions of electrons with oxygen, which produces 
the damaging reactive oxygen species (ROS), a mediator of damage in oxidative stress. The 
mechanism by which our body senses and reacts to hypoxia was brought to light through the 
discovery of hypoxia inducible factor 1 (HIF-1) and the delineation of its role as a master 
regulator of chronic oxygen homeostasis (Semenza 2008). HIF-1 is a heterodimeric protein that 
is composed of a constitutively expressed HIF-1β subunit and an O2-regulated HIF-1α subunit 
(Wang 1995). Since HIF-1α is regulated by changes in oxygen, it and the HIF-1 mechanistic 
pathway has been the primary focus on studies investigating chronic hypoxia in human and 
animal studies alike. HIF-1α controls a vast amount of protein, transcription factors, and 
metabolic processes to ensure that every cell receives adequate oxygen perfusion. Specifically, 
direct HIF-1α target genes help regulate two important processes of oxygen homeostasis; 
erythropoiesis, or red blood cell production, and angiogenesis, the branching of new blood 
vessels off existing ones to increase vasculature (Jelkmann 2007; Iyer 1998; Ceradini 2004; 
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Forsythe 1996; Kelly 2003).  During systemic tissue hypoxia, HIF-1 transciptional activity is 
induced in cells throughout the body, including specialized cells in the kidney that produce 
erythropoietin (EPO), a glycoprotein hormone that is secreted into the blood and binds to its 
cognate receptor (EPOR) on erythroid progenitor cells, thereby stimulating red blood cell 
survival and differentiation (Jelkmann 2007; Iyer 1998). In the developing fetus, EPO is 
produced not only by the fetal kidney, but also by the fetal liver and placenta until the kidney has 
developed enough to produce sufficient amounts on its own (Noguchi 2008). In contrast to the 
systemic role of EPO, angiogenesis represents a local tissue response to decreased oxygenation 
(Semenza 2008). As cells grow and proliferate, their consumption of O2 increases and HIF-1 
activity is induced, resulting in increases in a variety growth factors, including vascular 
endothelial growth factors (VEGFs) stromal-derived factor 1 (SDF-1), and placental growth 
factor (PLGF) (Ceradini 2004; Forsythe 1996; Kelly 2003).  
 
1.2.2.1 Chronic Hypoxia and Growth Restriction 
From an extremely early time point in gestation, the fetus is very sensitive and adaptive to 
changes in nutrient availability.  One of the first responses to a decrease in substrate delivery, 
such as oxygen, is a reduction in fetal growth (Peebles 2004). FGR is one of the major 
complications of antenatal hypoxic exposure in humans, with FGR arising from both acute and 
chronic levels of hypoxia at different time points throughout gestation (de Onis 1998). It is 
believed that restriction in fetal growth appears to be the most important factor in balancing 
reduced oxygen delivery and consumption. During prolonged oxygen deprivation, brain-sparing 
adaptations take effect, to ensure appropriate brain and heart development. This means that 
although cerebral metabolism is preserved and myocardial oxygen consumption may actually 
increase, oxygen consumption in muscle, kidney, gut, and lung may be decreased markedly 
(Braems 1991). This represents the adaptive response by the fetus to lowered oxygenation in the 
intrauterine environment. 
Fetal hypoxia is one of the most significant challenges facing obstetric clinical study, as it 
presents a large ethical concern for human cohorts. A low oxygen intrauterine environment can 
be generated through variety of adverse conditions, including placental insufficiency (Myatt 
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2010), preeclampsia (Roberts 2002) high-altitude environments (Moore 2001; Giussani 2001; 
Niermeyer 2009) and exposure to toxic substances (Julian 2009). Specifically, high-altitude 
living exposes particular problems and imposes a significant challenge to the pregnant woman 
and her developing fetus, and often result in low birth weight offspring and preeclampsia during 
pregnancy (Moore 2001; Giussani 2001; Niermeyer 2009). The risk of small size at birth due to 
lack of oxygen during fetal life is associated with the increased incidence of high blood pressure 
and heart disease in the adult offspring (Julian 2009). Similar to that seen with inadequate 
substrate availability due to placental insufficiency, when a fetus experiences hypoxic stress it 
redistributes its cardiac output to preferentially perfuse the heart and brain at the expense of other 
organs (Peeters 1979; Kitanaka 1989; Longo 1993). Recently, our lab has used a patient cohort 
from St. Joseph’s hospital in London, Ontario to show that low pre-pregnancy BMI is another 
contributor to both FGR with reduced umbilical O2 levels (Richardson 2014). Together, these 
studies demonstrate how chronic hypoxia can lead to various disruptions in normal fetal 
development and eventually to dysfunction and disorders in postnatal life.  
 
1.2.3 Oxidative Stress and Redox Homeostasis  
Oxidative stress occurs during an imbalance between ROS and a cells antioxidant capacity.  ROS 
can be produced naturally, as a biological by-product oxidative phosphorylation (the process that 
produces ATP) and play a major role in cell signalling (Zhang 2011). ROS can additionally be 
generated from environmental sources such as pollutants, tobacco, smoke, drugs, xenobiotics or 
radiation (Trachootham 2008).  To a lesser extent, ROS can be produced from endoplasmic 
reticulum (ER) during stress stimuli (Malholtra 2007). It has been suggested that low levels of 
ROS work in signalling pathways to promote a variety of beneficial activities, including cell 
proliferation, differentiation, while higher levels of ROS lead to the advantageous programmed 
cell death via apoptosis (Ye 2015). Therefore, ROS in lower quantities is beneficial and 
maintenance of this redox homeostasis is essential for proper cell functionality. 
A build-up of ROS due to oxygen imbalance can have a variety of damaging effects, including 
DNA damage, and inactivation of valuable amino acids, enzymes, and fatty acids (Brooker 
2011). During states whereby there is a chronic lack of oxygen (ie:hypoxia), this build-up of 
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ROS occurs from consistent anerobic production by the mitochondria where ROS are a natural 
by-product. This physiological stress can be demonstrated by measuring levels of cellular 
antioxidant molecules, enzymes involved in their production or in the reduction of ROS, and/or 
indexes of cellular damage due to oxidative stress (Hracsko 2008). For example, glutathione 
(GSH) is an abundent antioxidant and a free radical scavenger that is reduced to GSH after 
enzymatic interaction with free radicals. The ratio of GSH to its oxidized form (GSSG) is 
indicative of the antioxidant state of the cell, with a lower ratio signifying a cell undergoing 
oxidative stress (Schafer 2001; Owen 2010). Malondialdehyde (MDA) is a by-product of ROS 
lipid peroxidation that represents an index of cellular damage (Rice-Evans 1993). 8-
hydroxyguanosine (8-OHdG) has been used as a measure of DNA oxidative stress, and 3-
Nitrotyrosine (3NT) is used as an indicator or marker of cell damage due to the buildup of ROS 
such as peroxynitrite anion and nitrogen dioxide (NO2) (Mohiuddin 2006; Pacher 2007). 
Under normal physiological conditions, when an increase in ROS and oxidative stressors is 
detected, the endogenous cellular defense system is activated. This consists of a number of 
antioxidants that protect the cell by maintaining a desirable redox status. Many antioxidants, 
including peroxiredoxins (PRDX) which are controlled by the thioredoxin (THX) class of redox 
proteins, the oxidized form of glutathione, superoxide dismutase (SOD) and catalases act directly 
on ROS to inactivate them (Reddy 2008). These enzymes are at the forefront of a defensive and 
protective system in place to ensure long-term chronic oxidative stress from exposure to ROS 
can be avoided.  
 
1.2.3.2 Clinical Studies of Oxidative Stress and Aberrant Development 
The role of oxidative stress in fetal programming is supported by epidemiological evidence of 
oxidant indices and low birth weight in association with type 2 diabetes (Peuchant 2004), 
cardiovascular disease (Bloc 2002) and preeclampsia (Roberts 2002). Thus, it follows that 
oxidative stress may be an additional mechanism for intrauterine insult and programming 
consequences after birth. Studies have shown that oxidative stress plays an important role in 
FGR pregnancies resulting from placental insufficiency, preeclampsia, and maternal 
undernourishment.  Umbilical cord plasma from FGR pregnancies have been found to have 
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increased levels of oxidative stress markers, including MDA and xanthine oxidase, while the 
levels of antioxidant potential were identified to be lower in maternal plasma, umbilical cord 
plasma, and placental tissues of the patients with FGR (Biri 2007). Other studies have found that 
FGR pregnancies have increased markers for both oxidative DNA damage and antioxident 
function, including 8-OHdG, 4-hydroxynonenal (4-HNE), (TRX), and redox factor-1 which are 
enhanced in cases of FGR with preeclampsia  (Takagi 2004; Thompson 2012). Interestingly, 
some studies such as Hracsko et al., have reported decreases in antioxidant enzyme activity and 
the levels of antioxidants, which suggest a level of defensive deficiency in cases of FGR. It was 
found that that both were significantly lower in the FGR group of neonates, while damage of 
proteins and DNA was slightly, but non-significantly, higher in the FGR group (Hracsko 2008). 
Human cases of maternal undernourishment-induced FGR have also reported an increase in 
markers of oxidative stress. In particular, Gupta et al.. (2004) showed increased oxidative stress 
in FGR fetuses born to undernourished mothers through the measure of SOD, catalase, 
glutathione (GSH), and malondialdehyde (MDA) in cord blood. Together these studies indicate a 
strong link between sub-optimal fetal growth and oxidative stress, which suggest oxidative stress 
associated with pregnancy complications may be a contributing factor in postnatal consequences 
of FGR. 
 
1.3 ANIMAL MODELS OF FGR AND ADVERSE DEVELOPMENT 
1.3.1 Animal Studies of FGR with Placental Insufficiency  
From the clinical study of FGR arising from placental insufficiency, one of the major 
contributors is aberrant placental vascularization and associated decreases in umbilical blood 
flow. These changes have directed research focus to animal models of placental insufficiency 
induced by a variety of pre-pregnancy, mid-pregnancy and later pregnancy interventions. Pre-
pregnancy uterine carunclectomy, the removal of endometrial tissue of the placenta, resulted in 
decreased fetal weight as well as increased brain weight to fetal weight ratio in the fetal sheep 
(Robinson 1979). These fetuses also display markers implicating hypoxaemia and hypoglycemia 
compared to controls with intact placentae (Robinson 1979).  Mid-pregnancy exposure to 
hypothermic environments in ewes resulted in altered placental hormone concentrations most 
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likely due to impaired trophoblast cell development, which was an additional causative factor for 
FGR arising from placental insufficiency (Regnault 1999). Models of later pregnancy 
perturbations include uterine artery ligation (UAL)/ablation, where the uterine artery is ligated 
midway through gestation, which has been shown to result in aFGR with fetal brain and adrenal 
weight being less affected then that of controls in the guinea pig (Lafeber 1984; Turner 2009). 
Furthermore, uterine artery ligation in rodent (Olivier 2007) and sheep (Rees 1999) has been a 
popular technique to induce FGR, with decreases in fetal brain development and long-term brain 
function. UAL in guinea pigs has resulted in decreased placental size and placental substrate 
transfer (Jansson 1990), as well as shown reduced oxygen and nutrient delivery (Jones 1983; 
Lafeber 1984), which successfully mimics human placental insufficiency. More recently, our lab 
has demonstrated how UAL in pregnant guinea pigs leads to decreases in synapse formation, 
myelination and maturation of synapses in the hippocampal brain regions of the fetus 
(Piorkowska 2014). Finally, placental embolization, whereby the placenta is partially removed 
midway through gestation, results in aFGR with evidence for chronic hypoxemia in the fetal 
sheep (Murotsuki 1997; Gagnon 1997). Together, these various techniques and methods 
primarily used in sheep, rats, and guinea pigs, lead to FGR with variable hypoxemia and nutrient 
restriction. However, while certainly successful for inducing growth restriction, these 
UAL/cauterization/embolization models have also reported very high pup mortality relative to 
the human condition, up to 50% in the guinea pig (Turner 2009). While these models are 
representative of aberrant placental development as seen with human cases of FGR and placental 
insufficiency, they involve a one time, invasive procedure that results in variable severity and 
timing that doesn’t always closely parallel the human condition.  
 
1.3.2 Animal Studies of FGR with Maternal Undernourishment   
As stated, clinical study of undernutrition is dependent on a variety of factors, most prominently 
the timing of undernourishment pre-conception and throughout pregnancy as well as the severity 
of undernutrition. As a result, there have been many animal models targeted at investigating the 
impact of global or total calorie maternal feed restriction on fetal and placental growth and 
development. These studies, primarily using sheep and guinea pigs, have used a variety of 
moderate to severe restriction of feed resulting in a range of different levels growth restriction 
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and altered development. Typically, moderate feed restriction has been characterized as 70-85% 
of a control ad libitum diet, and severe restriction studies usually use around 50% feed restriction 
to mimic extreme maternal undernourishment. Overall, growth restriction midway through 
pregnancy in guinea pigs tends to result in changes in the placenta over the fetus, and maternal 
nutrient restriction (MNR) starting pre-conception and lasting throughout pregnancy results in 
altered fetal and placental weights (Roberts 2001a). Severe maternal restriction studies, using a 
50% dietary restriction have led to deceased placental weight in the sheep, and while severe 
restriction midway through pregnancy interestingly did not lead to any changes to overall fetal 
weight; it did result in altered fetal dimensions indicating an organ sparing effect (Heasman 
1999). Also, a 50% feed restriction in the maternal ewe has been shown to increase growth 
factors, arterial blood pressure, and decrease fetal plasma glucose concentration (Edwards 2001). 
FGR has been reported when the severe growth restriction is applied starting early on in 
gestation (Vonnahme 2003). These studies resulted in fetuses that were markedly smaller, had 
reduced fetal and maternal blood glucose levels, but with unaltered placental weight changes 
(Vonnahme 2003).  Studies of moderate nutrient restriction, usually involving 70-80% of the 
control feed intake, have also shown to decidedly impact fetal-placental growth during 
preconception food restriction (MacLaughlin 2005). This study examined how even during 
preconception and ending on day 7 of gestation, maternal weight due to undernutrition impacts 
fetal and placental weight at birth, implicating long-term consequences as seen with human FGR 
as seen with placental insufficiency.  Global MNR during early to mid-pregnancy in sheep 
increased the placental weight:fetal weight ratio by enhancing placental weight at term without 
altering fetal weight (Heasman 1998) . Conversely, a 50% maternal undernourishment during the 
second half of rat pregnancy yielded a decrease in the placental weight:fetal weight ratio 
(Belkacemi  2009). Together, these results suggest that MNR permanently affects placental 
weight when nutrient deprivation coincides with the time when fetal nutrient demand is maximal. 
The guinea pig has also been used extensively to study MNR and fetal growth and development. 
A group from Australia used moderate MNR in guinea pigs pre-conception and throughout 
pregnancy lead to changes in growth factors that resulted in altered development (Sohlstrom, 
1998). In addition to decreased fetal and placental growth measures, Roberts and colleges found 
impactful structural and functional changes in the developing placenta when mothers were 
subjected to a moderate MNR diet pre-conception and throughout pregnancy. These changes 
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included increased barrier thickness, decreased placenta labyrinth, and therefore decreased 
availability for oxygen exchange between mother and fetus (Roberts 2001a, Roberts 2001b). 
These fetal guinea pigs, because of moderate MNR, also had increased glucose tolerance levels, 
growth factors such as IGFs, and adiposity compared to control counterparts (Roberts 2001b).  
 
1.3.3 Animal Studies of Altered Development with Hypoxia 
Due to the drastic effect of maternal or environmental hypoxia fetal growth and development, 
combined with the complications of studying chronic hypoxia in human FGR, there is 
considerable interest in using animal models in the study of hypoxia-induced FGR. These 
studies, primarily in sheep and guinea pigs, have been studied extensively the effects of both 
chronic and acute hypoxia on fetal development. Experimentally, chronic hypoxia (over days to 
weeks or even months) can be initiated early or late in gestation in the sheep and can be induced 
through placental embolization (Boyle 1984; Gagnon 1997), placental insufficiency via 
caruncletomy (Robinson 1979; Robinson 1994), or by high altitude resulting in moderate 
continuous hypoxia with normal pregnancy duration and varying degrees of growth restriction 
(Harvey 1993; Imamura 2004; Kamitomo 1992). Studies of placental embolization have resulted 
in growth restriction with progressive hypoxemia with reduced fetal plasma adrenocorticotropic 
hormone (ACTH) but increased prostaglandin E2 as a marker of fetal stress (Gagnon 1997). 
Another study, using the caruncletomy model to induce placental insufficiency, reported FGR 
with fetal arterial PO2 levels reduced by 30%, and associated increases in cortisol levels (Phillips 
1996). Another study found decreased protein synthesis in the fetal sheep with a corresponding 
decrease in overall oxygen consumption of up to 10% (Richardson 1998). Richardson also 
reported that growth restriction can so successfully reduce oxygen consumption that the arterial 
oxygen concentration can be maintained or only minimally decreased until substrate delivery is 
severely restricted (Richardson 1998).  In the guinea pig, exposure to chronic hypoxia 
demonstrated an over 10-fold increase in expression levels of hypoxia index genes such as EPO 
and HIF-1α, and an over 40% reduction in neuronal density, implicating prenatal brain damage 
(Blutstein 2013; Kim 2014). Furthermore, pregnant guinea pigs placed in hypoxic chambers have 
resulted in fetuses that are FGR, with increased oxidative stress and pro-inflammatory markers in 
the fetal heart and liver (Evans 2012a, Oh 2008; Al-Hasan 2012; Oh 2007), as well as 
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differentially altered apoptotic and necrotic factors in the fetal brain (Evans 2012b). These 
studies in the sheep and guinea pig suggest that chronic hypoxia can induce FGR with additional 
mediators of damage, including oxidative stress, and combined these factors play a considerable 
role in long-term fetal programming.  
 
1.3.4 Animal Studies of Oxidative Stress and Aberrant Development 
As further support that oxidative stress acts as a mechanism of altered fetal development and 
consequences later in life, animal models of FGR and hypoxia have reported elevated makers of 
oxidative stress in both fetal and adult offspring. Prenatal hypoxia has been shown to generate 
oxidative stress in fetal hearts in a variety of animal species, including sheep (Derks 2010), rat 
(Giussani 2012; Zhang 2005), and guinea pig (Thompson 2005; Evans 2012a; Dong 2006). 
Taken together, these studies suggest that oxidative stress influences the fetal heart and initiates 
cardiovascular alterations in offspring. Further work done suggests other fetal and placental 
tissues impacted by hypoxia and oxidative stress are causative of adverse developmental 
programming. One such study, by Oh et al., found that late-onsetting, chronic maternal hypoxia 
increased total glutathione levels in the fetal liver, and also increased gamma glutamylcysteine 
synthetase (γ-GCS) protein levels in the fetal liver, kidney and lung (Oh 2008). Prenatal hypoxia 
increased DNA fragmentation and lipid peroxidation in fetal guinea pig livers, which was 
reversed by the antioxidant, N-acetylcysteine (Hashimoto 2012).  Hypoxia during gestation 
decreases insulin-signaling proteins in livers of rat offspring (Rueda-Clausen 2011) Overall, 
reduced fetal oxygenation from hypoxia may be responsible for organ-specific damage via 
oxidative stress. 
 
1.4 SUMMARY 
Fetal growth restriction is failure to attain proper developmental growth during intrauterine life. 
It can be present as both symmetrical or an asymmetrical growth restriction, without or with a 
brain sparing effect. FGR can arise from a combination of maternal, placental and genetic 
factors, the most common being abnormal placental development in developed countries or 
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undernourishment in developing countries. Overall, placental dysfunction leads to the inability to 
transport nutrients and oxygen to the fetus.  This growth restriction leads to an increased risk for 
many adverse outcomes throughout life, including cardiovascular, metabolic and cognitive 
disorders, which has spurred investigative interests towards the Developmental Origins of Health 
and Disease. Clinical study of the potential primary mechanisms behind FGR; placental 
insufficiency, hypoxia and oxidative stress, are complicated and relies on the ability to control 
many variables. This has led to many animals models of FGR, using a variety of techniques to 
mimic the human condition. Although the connection between placental insufficiency and 
increased hypoxia and oxidative stress are known, little work has been done to study if similar 
results are found in models of maternal nutrient restriction. Accordingly, it will be important to 
determine the extent to which fetal hypoxia and related oxidative stress also occur with growth 
restriction resulting from maternal undernourishment, and thereby the potential for treatment 
aimed at decreasing placental-fetal oxidative stress. 
 
19 
 
1.5 REFERENCES  
Adair LS, Pollitt E. (1985) Outcome of maternal nutritional supplementation: a comprehensive 
review of the Bacon Chow study. Am J Clin Nutr. 41(5):948-78 
Al-Hasan YM, Evans LC, Pinkas GA, Dabkowski ER, Stanley WC, Thompson LP. (2012) 
Chronic hypoxia impairs cytochrome oxidase activity via oxidative stress in selected fetal 
Guinea pig organs. Reprod Sci. (3):299-307. 
al Riyami N, Walker MG, Proctor LK, Yinon Y, Windrim RC, Kingdom JC. (2011) Utility of 
head/abdomen circumference ratio in the evaluation of severe early-onset intrauterine 
growth restriction. J Obstet Gynaecol Can. 33(7):715-9 
Barker DJ. (2004) The developmental origins of adult disease. J Am Coll Nutr 23(6 Suppl):588S-
95S 
Barker DJ. (2002) Fetal origins of adult disease: strength of effects and biological basis. Int J 
Epidemiol. 31(6):1235-9 
Barker DJ (1999) Fetal origins of cardiovascular disease. Ann Med. 31 Suppl 1:3-6 
Barker DJP. (1998) In utero programming of chonic disease. Clin Sci. 95:115-128 
Barker DJ, Osmond C, Simmonds SJ, Wield GA. (1993a) The relation of small head 
 circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 
306:422-426 
Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH. (1993b) Growth in utero and 
 serum cholesterol concentrations in adult life. BMJ 307:1524-1527 
Belkacemi L, Nelson DM, Desai M, Ross MG. (2010) Maternal undernutrition influences 
placental-fetal development. Biol Reprod 83(3):325-31 
20 
 
Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. (2000) Morbidity and mortality 
among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont 
Oxford Network. Am J Obstet Gynecol.182:198-206 
Biri A, Bozkurt N, Turp A, Kavutcu M, Himmetoglu O, Durak I. (2007) Role of oxidative stress 
in intrauterine growth restriction. Gynecol Obstet Invest. (4):187-92.  
Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L. (2002) Factors 
associated with oxidative stress in human populations. Am J Epidemiol. 156(3):274-85 
Blutstein T1, Castello MA, Viechweg SS, Hadjimarkou MM, McQuail JA, Holder M, Thompson 
LP, Mong JA. (2013) Differential responses of hippocampal neurons and astrocytes to 
nicotine and hypoxia in the fetal guinea pig. Neurotox Res. 24(1):80-93.  
Boo JF. (2006) Understanding heart failure. Arch Cardiol Mex. 76(4):431-47 
Boyle JW, Lotgering FK, Longo LD. (1984) Acute embolization of the uteroplacental 
circulation: uterine blood flow and placental CO diffusing capacity. J Dev Physiol. 
6(4):377-86. 
Brandt I, Sticker EJ, Lentze MJ. (2003) Catch-up growth of head circumference of very low birth 
weight, small for gestational age preterm infants and mental development to adulthood. J 
Pediatr.142(5):463-8 
Braems G, Jensen A. (1991) Hypoxia reduces oxygen consumption of fetal skeletal muscle cells 
in monolayer culture. J Dev Physiol. (4):209-15 
Brooker, RJ. (2011) Genetics: analysis and principles (4th ed.). McGraw-Hill Science. ISBN 
978-0-07-352528-0 
Campbell A and Thoms A. (1977) Ultrasound measure of the fetal head to abdomen 
circumferences ratio in the assessment of growth retardation. Brit J Obstet Gynaecol. 
84:165-74 
21 
 
Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, 
Galiano RD, Levine JP, Gurtner GC. (2004) Progenitor cell trafficking is regulated by 
hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. (8):858-64.  
Cetin I, Foidart JM, Miozzo M, Raun T, Jansson T, Tsatsaris V, Reik W, Cross J, Hauguel-de-
Mouzon S, Illsley N, Kingdom J, Huppertz B. (2004) Fetal growth restriction: a workshop 
report. Placenta. 25(8-9):753-7 
Cosmi E, Fanelli T, Visentin S, Trevisanuto D, Zanardo V. (2011) Consequences in infants that 
were intrauterine growth restricted. J Pregnancy. 2011:364381. 
Cox WL, Daffos F, Forestier F, Descombey D, Aufrant C, Auger MC, Gaschard JC. (1988) 
Physiology and management of intrauterine growth retardation: a biologic approach with 
fetal blood sampling. Am J Obstet Gynecol. 159(1):36-41 
de Onis M1, Blössner M, Villar J. (1998) Levels and patterns of intrauterine growth retardation 
in developing countries. Eur J Clin Nutr. 52 Suppl 1:S5-15 
Derks JB, Oudijk MA, Torrance HL, Rademaker CM, Benders MJ, Rosen KG, Cindrova-Davies 
T, Thakor AS, Visser GH, Burton GJ, van Bel F, Giussani DA. (2010) Allopurinol reduces 
oxidative stress in the ovine fetal cardiovascular system after repeated episodes of 
ischemia-reperfusion. Pediatr Res. 68(5):374-80 
Dong Y, Thompson LP. (2006) Differential expression of endothelial nitric oxide synthase in 
coronary and cardiac tissue in hypoxic fetal guinea pig hearts. J Soc Gynecol Investig. 
13(7):483-90  
Edwards LJ, McMillen IC. (2001) Maternal undernutrition increases arterial blood pressure in 
the sheep fetus during late gestation. J Physiol. 533(Pt 2):561-70 
Evans LC, Liu H, Pinkas GA, Thompson LP. (2012a) Chronic hypoxia increases peroxynitrite, 
MMP9 expression, and collagen accumulation in fetal guinea pig hearts. Pediatr Res 
(1):25-31 
22 
 
Evans LC, Liu H, Thompson LP. (2012b) Differential effect of intrauterine hypoxia on caspase 3 
and DNA fragmentation in fetal guinea pig hearts and brains. Reprod Sci. 19(3):298-305 
Feng S. (2005) Management of preterm infants with intrauterine growth restriction. Early Hum 
Dev. 81:9-900 
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. (1996) 
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible 
factor 1. Mol Cell Biol. 16(9):4604-13 
Gagnon R1, Murotsuki J, Challis JR, Fraher L, Richardson BS. (1997) Fetal sheep endocrine 
responses to sustained hypoxemic stress after chronic fetal placental embolization. Am J 
Physiol. 272(5 Pt 1):E817-23 
Gardner JM, Walker SP, Powell CA, Grantham-McGregor S. (2003) A randomized controlled 
trial of a home-visiting intervention on cognition and behavior in term low birth weight 
infants. J Pediatr. 143(5):634-9 
Giussani DA, Camm EJ, Niu Y, Richter HG, Blanco CE, Gottschalk R, Blake EZ, Horder KA, 
Thakor AS, Hansell JA, Kane AD, Wooding FB, Cross CM, Herrera EA. (2012) 
Developmental programming of cardiovascular dysfunction by prenatal hypoxia and 
oxidative stress. PLoS One. 7(2):e31017 
Giussani DA, Phillips PS, Anstee S, Barker DJ. (2001) Effects of altitude versus economic status 
on birth weight and body shape at birth. Pediatr Res. 49(4):490-4 
Ghidini A. (1996)Idiopathic fetal growth restriction: a pathophysiologic approach. Obstet 
Gynecol Surv. 51(6):376-82 
Halliday HL. (2009) Neonatal management and long-term sequelae. Best Pract Res Clin Obstet 
Gynaecol. 23(6):871-80 
Han VK. (1993) Pathophysiology, cellular and molecular mechanisms of fetal growth 
retardation. Equine Vet J Suppl. (14):12-6 
23 
 
Harvey LM, Gilbert RD, Longo LD, Ducsay CA. (1993) Changes in ovine fetal adrenocortical 
responsiveness after long-term hypoxemia. Am J Physiol. 264(5 Pt 1):E741-7 
Hashimoto K, Pinkas G, Evans L, Liu H, Al-Hasan Y, Thompson LP. (2012) Protective effect of 
N-acetylcysteine on liver damage during chronic intrauterine hypoxia in fetal guinea pig. 
Reprod Sci. 19(9):1001-9 
Heasman L, Clarke L, Stephenson TJ, Symonds ME. (1999) The influence of maternal nutrient 
restriction in early to mid-pregnancy on placental and fetal development in sheep. Proc 
Nutr Soc. 58(2):283-8 
Hracsko Z, Orvos H, Novak Z, Pal A, Varga IS. (2008) Evaluation of oxidative stress markers in 
neonates with intrauterine growth retardation. Redox Rep 13: 11-16 
Imamura T, Umezaki H, Kaushal KM, Ducsay CA. (2004) Long-term hypoxia alters endocrine 
and physiologic responses to umbilical cord occlusion in the ovine fetus. J Soc Gynecol 
Investig. 11(3):131-40 
Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, 
Lawler AM, Yu AY, Semenza GL. (1998) Cellular and developmental control of O2 
homeostasis by hypoxia-inducible factor 1α. Genes Dev 12: 149–162 
Jang DG, Jo YS, Lee SJ, Kim N, Lee GS. (2011) Perinatal outcomes and maternal clinical 
characteristics in IUGR with absent or reversed end-diastolic flow velocity in the umbilical 
artery. Arch Gynecol Obstet. 284(1):73-8 
Jansson T, Powell TL. (2007) Role of the placenta in fetal programming: underlying mechanisms 
and potential interventional approaches. Clin Sci (Lond). 113(1):1-13 
Jansson T, Persson E. (1990) Placental transfer of glucose and amino acids in intrauterine growth 
retardation: studies with substrate analogs in the awake guinea pig. Pediatr Res. 28(3): 
203-8 
Jelkmann W. (2007) Control of erythropoietin gene expression and its use in medicine. Methods 
Enzymol 435: 179–197 
24 
 
Jones CT, Parer JT. (1983) The effect of alterations in placental blood flow on the growth of and 
nutrient supply to the fetal guinea-pig. J Physiol. 343:525-37 
Julian CG, Wilson MJ, Lopez M, Yamashiro H, Tellez W, Rodriguez A, Bigham AW, Shriver 
MD, Rodriguez C, Vargas E, Moore LG. (2009) Augmented uterine artery blood flow and 
oxygen delivery protect Andeans from altitude-associated reductions in fetal growth. Am J 
Physiol Regul Integr Comp Physiol. 296(5):R1564-75 
Kamitomo M, Longo LD, Gilbert RD. (1992) Right and left ventricular function in fetal sheep 
exposed to long-term high-altitude hypoxemia. Am J Physiol. 262(2 Pt 2):H399-405 
Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, 
Campochiaro PA, Semenza GL. (2003) Cell type-specific regulation of angiogenic growth 
factor gene expression and induction of angiogenesis in nonischemic tissue by a 
constitutively active form of hypoxiainducible factor 1. Circ Res 93: 1074–1081 
Kim J, Choi IY, Dong Y, Wang WT, Brooks WM, Weiner CP, Lee P. (2014) Chronic fetal 
hypoxia affects axonal maturation in guinea pigs during development: A longitudinal 
diffusion tensor imaging and T2 mapping study. J Magn Reson Imaging. doi: 
10.1002/jmri.24825. [Epub ahead of print] 
Kingdom J, Huppertz B, Seaward G, Kaufmann P. (2000) Development of the placental villous 
tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol. 92(1):35-43 
Kitanaka T, Alonso JG, Gilbert RD, Siu BL, Clemons GK, Longo LD. (1989) Fetal responses to 
long-term hypoxemia in sheep. Am J Physiol. 256(6 Pt 2):R1348-54 
Kramer MS, Olivier M, McLean FH, Willis DM, Usher RH. (1990) Impact of intrauterine 
growth retardation and body proportionality on fetal and neonatal outcome. Pediatrics 
86:707-13 
Kramer MS. (2003) The epidemiology of adverse pregnancy outcomes: an overview. J Nutr. 
133(5 Suppl 2):1592S-1596S 
25 
 
Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. (2001) The risks of spontaneous 
preterm delivery and perinatal mortality inr elation to size at birth according to fetal versus 
neonatal growth standards. Am J Obstet Gynecol. 184:946-53 
Lafeber HN, Rolph TP, Jones CT. (1984) Studies on the growth of the fetal guinea pig. The 
effects of ligation of the uterine artery on organ growth and development. J Dev Physiol. 
6(6):441-59 
Langley-Evans SC. (2009) Nutritional programming of disease: unravelling the mechanism. J 
Anat. 215(1):36-51 
Liu J. (2014) Clinical analysis of 126 cases of severe precocious preeclampsia complicated with 
fetal growth retardation. Zhonghua Yi Xue Za Zhi. 94(37):2945-7 
Longo LD, Hull AD, Long DM, Pearce WJ. (1993) Cerebrovascular adaptations to high-altitude 
hypoxemia in fetal and adult sheep. Am J Physiol. 264(1 Pt 2):R65-72. 
Lumey LH. (1998) Compensatory placental growth after restricted maternal nutrition in early 
pregnancy. Placenta 19(1):105-11 
MacLaughlin SM, Walker SK, Roberts CT, Kleemann DO, McMillen IC. (2005) 
Periconceptional nutrition and the relationship between maternal body weight changes in 
the periconceptional period and feto-placental growth in the sheep. J Physiol. 565(Pt 
1):111-24 
Mahendran D, Donnai P, Glazier JD, D'Souza SW, Boyd RD, Sibley CP. (1993) Amino acid 
(system A) transporter activity in microvillous membrane vesicles from the placentas of 
appropriate and small for gestational age babies. Pediatr Res. 34(5):661-5 
Malhotra JD, Kaufman RJ. (2007) Endoplasmic reticulum stress and oxidative stress: a vicious 
cycle or a double-edged sword? Antioxid Redox Signal 9(12):2277-93 
Mohiuddin I, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. (2006) Nitrotyrosine and 
chlorotyrosine: clinical significance and biological functions in the vascular system. J. 
Surg. Res. 133 (2): 143–9 
26 
 
Moore LG, Zamudio S, Zhuang J, Sun S, Droma T. (2001) Oxygen transport in tibetan women 
during pregnancy at 3,658 m. Am J Phys Anthropol. 114(1):42-53 
Murotsuki J, Challis JR, Han VK, Fraher LJ, Gagnon R. (1997) Chronic fetal placental 
embolization and hypoxemia cause hypertension and myocardial hypertrophy in fetal 
sheep. Am J Physiol. =272(1 Pt 2):R201-7 
Myatt L. (2006) Placental adaptive responses and fetal programming. J Physiol. 572(Pt 1):25-30 
Myatt L. (2010) Review: Reactive oxygen and nitrogen species and functional adaptation of the 
placenta. Placenta. 31 Suppl:S66-9 
Niermeyer S, Andrade Mollinedo P, Huicho L. (2009) Child health and living at high altitude. 
Arch Dis Child. 94(10):806-11 
Oh C, Dong Y, Harman C, Mighty HE, Kopelman J, Thompson LP. (2008) Chronic hypoxia 
differentially increases glutathione content and y-glutamyl cysteine synthetase expression 
in fetal guinea pig organs. Early Hum Dev 84: 121-127 
Oh C, Dong Y, Liu H, Thompson LP. (2007) Intrauterine hypoxia upregulates proinflammatory 
cytokines and matrix metalloproteinases in fetal guinea pig hearts. Am J Obstet Gynecol. 
199(1):78 
Olivier P1, Baud O, Bouslama M, Evrard P, Gressens P, Verney C. (2007) Moderate growth 
restriction: deleterious and protective effects on white matter damage. Neurobiol Dis. 
26(1):253-63 
Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease.". 
Physiol Rev. 87 (1): 315–424 
Pallotto EK and Kilbride HW. (2006) Perinatal outcome and later implications of intrauterine 
growth restriction. Clin Obstet Gynecol. 49(2):257-69 
Peebles DM. (2004) Fetal consequences of chronic substrate deprivation. Semin Fetal Neonatal 
Med. 9(5):379-86 
27 
 
Peeters LL, Sheldon RE, Jones MD Jr, Makowski EL, Meschia G. (1979) Blood flow to fetal 
organs as a function of arterial oxygen content. Am J Obstet Gynecol. 135(5):637-46 
Peuchant E1, Brun JL, Rigalleau V, Dubourg L, Thomas MJ, Daniel JY, Leng JJ, Gin H. (2004) 
Oxidative and antioxidative status in pregnant women with either gestational or type 1 
diabetes. Clin Biochem37(4):293-8 
Phillips ID, Simonetta G, Owens JA, Robinson JS, Clarke IJ, McMillen IC. (1996) Placental 
restriction alters the functional development of the pituitary-adrenal axis in the sheep fetus 
during late gestation. Pediatr Res. 40(6):861-6 
Piorkowska K, Thompson J, Nygard K, Matushewski B, Hammond R, Richardson B. (2014) 
Synaptic development and neuronal myelination are altered with growth restriction in fetal 
guinea pigs. Dev Neurosci. 36(6):465-76 
Piper JM, Xenakis EM, McFarland M, Elliott BD, Berkus MD, Langer O. (1996) Do growth 
retarded premature infants have different rates of perinatal morbidity and mortality than 
appropriately grown premature infants? Obstet Gynecol. 169-74 
Pollack RN and Divon MY. (1992) Intrauterine growth retardation; Definition, classification, 
and etiology. Clin Obstet Gyne. 35:99-107 
Ravelli AC1, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, Bleker OP. 
(1998) Glucose tolerance in adults after prenatal exposure to famine. Lancet. 
351(9097):173-7 
Reddy, SP. (2008) The antioxidant response element and oxidative stress modifers in airway 
diseases. Curr Mol Med 8(5): 376–383 
Rees S, Breen S, Loeliger M, McCrabb G, Harding R. (1999) Hypoxemia near mid-gestation has 
long-term effects on fetal brain development. J Neuropathol Exp Neurol. 58(9):932-45 
Regnault TR, Orbus RJ, Battaglia FC, Wilkening RB, Anthony RV. (1999) Altered arterial 
concentrations of placental hormones during maximal placental growth in a model of 
placental insufficiency. J Endocrinol. 162(3):433-42 
28 
 
Rice-Evans C, Burdon R. (1993) Free radical lipid interactions and their pathological 
consequences. Prog Lipid Res 32: 71-110 
Richardson BS, Ruttinger S, Brown H, deVrijer B. (2014) Maternal Body Mass Index Impacts 
Fetal-Placental Size at Birth and Umbilical Cord Oxygen Values: Implications for 
Regulatory Mechanisms. Placenta. Submitted Nov. 2014 
Roberts JM, Lain KY. (2002) Recent Insights into the pathogenesis of pre-eclampsia. Placenta. 
23(5):359-72 
Roberts CT, Sohlstrom A, Kind KL, et al... (2001a) Maternal food restriction reduces the 
exchange surface area and increases the barrier thickness of the placenta in the guinea-pig. 
Placenta 22(2-3):177-85 
Roberts CT, Sohlstrom A, Kind KL, et al... (2001b) Altered placental structure induced by 
maternal food restriction in guinea pigs: a role for circulating IGF-II and IGFBP-2 in the 
mother? Placenta 22 Suppl A:S77-S82 
Robinson JS, Seamark RF, Owens JA. (1994) Placental function. Aust N Z J Obstet Gynaecol. 
34(3):240-6 
Robinson JS, Kingston EJ, Jones CT, Thorburn GD. (1979) Studies on experimental growth 
retardation in sheep. The effect of removal of a endometrial caruncles on fetal size and 
metabolism. J Dev Physiol. 1(5):379-98 
Rodríguez G, Collado MP, Samper MP, Biosca M, Bueno O, Valle S, Ventura P, Garagorri JM. 
(2011) Subcutaneous fat distribution in small for gestational age newborns. J Perinat Med. 
39(3):355-7 
Rueda-Clausen CF, Dolinsky VW, Morton JS, Proctor SD, Dyck JR, Davidge ST. (2011) 
Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-
fat diet-induced metabolic syndrome. Diabetes. 60(2):507 
Salafia CM, Charles AK, Maas EM. (2006) Placenta and fetal growth restriction. Clin Obstet 
Gynecol. 49(2):236-56 
29 
 
Schafer FQ, Buettner GR. (2001) Redox environment of the cell as viewed through the redox 
state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212 
Semenza GL. (2009) Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1. 
Physiology 24: 97–106 
Seeds JW, Peng T. (1998) Impaired growth and risk of fetal death: is the tenth percentile the 
appropriate standard? Am J Obstet Gynecol. 178:658-69 
Sohlstrom A, Katsman A, Kind KL, et al... (1998) Food restriction alters pregnancy-associated 
changes in IGF and IGFBP in the guinea pig. Am J Physiol. 274(3 Pt 1):E410-E416 
Strauss RS. (2000) Adult functional outcome of those born small for gestational age: twenty-six-
year follow-up of the 1970 British Birth Cohort. JAMA. 283(5):625-32 
Strauss RS, Dietz WH. (1997) Effects of intrauterine growth retardation in premature infants on 
early childhood growth. J Pediatr. 130(1):95-102 
Synnes AR, Anson S, Arkesteijn A, Butt A, Grunau RE, Rogers M, Whitfield MF. (2010) School 
entry age outcomes for infants with birth weight ≤ 800 grams. J Pediatr. 157(6):989-994 
Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, Ohira S, Konishi I. (2004) Levels of 
oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal 
growth restriction. Virchows Arch 444: 49-55 
Thompson LP, Dong Y. (2005) Chronic hypoxia decreases endothelial nitric oxide synthase 
protein expression in fetal guinea pig hearts. J Soc Gynecol Investig. 12(6):388-95 
Thompson LP, Al-Hasan Y. (2012) Impact of oxidative stress in fetal programming. J Pregnancy 
2012: 582748 
Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. (2008) Redox regulation of cell 
survival. Antioxid Redox Signal. 10(8):1343-74 
Turner AJ, Trudinger BJ. (2009) A modification of the uterine artery restriction technique in the 
guinea pig fetus produces asymmetrical ultrasound growth. Placenta 30(3):236-40 
30 
 
Villar J, Smeriglio V, Martorell R, Brown CH, Klein RE. (1984) Heterogeneous growth and 
mental development of intrauterine growth-retarded infants during the first 3 years of life. 
Pediatrics. 74(5):783-91 
Vonnahme KA, Hess BW, Hansen TR, et al... (2003) Maternal undernutrition from early- to 
mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased 
liver weight in the fetal sheep. Biol Reprod. 69(1):133-40 
Waber DP, Vuori-Christiansen L, Ortiz N, Clement JR, Christiansen NE, Mora JO, Reed RB, 
Herrera MG. (1981) Nutritional supplementation, maternal education, and cognitive 
development of infants at risk of malnutrition. Am J Clin Nutr. 34(Suppl 4):807-13 
Walker SP, Wachs TD, Gardner JM, Lozoff B, Wasserman GA, Pollitt E, Carter JA; 
International Child Development Steering Group. (2007) Child development: risk factors 
for adverse outcomes in developing countries. Lancet. 369(9556):145-57 
Walker SP1, Chang SM, Powell CA, Grantham-McGregor SM. (2004) Psychosocial intervention 
improves the development of term low-birth-weight infants. J Nutr. 134(6):1417-23 
Wang GL, Jiang BH, Rue EA, Semenza GL. (1995) Hypoxia-inducible factor 1 is a basic-helix-
loophelix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci 5510–
5514 
Ye ZW, Zhang J, Townsend DM, Tew KD. (2015) Oxidative stress, redox regulation and 
diseases of cellular differentiation. Biochim Biophys Acta. 1850(8):1607-1621 
Zhang Y, Zhao S, Gu Y, Lewis DF, Alexander JS, Wang Y. (2005) Effects of peroxynitrite and 
superoxide radicals on endothelial monolayer permeability: potential role of peroxynitrite 
in preeclampsia. J Soc Gynecol Investig. (8):586-92 
Zhang Y, Du Y, Le W, Wang K, Kieffer N, Zhang J. (2011) Redox control of the survival of 
healthy and diseased cells. Antioxid Redox Signal. 15(11):2867-908 
  
31 
 
 
 
 
 
 
CHAPTER 2 
RATIONALE, HYPOTHESIS, AND RESEARCH OBJECTIVES 
32 
 
2.1 RATIONALE 
Fetal growth restriction (FGR) with birth weight < 3rd, 5th, or 10th percentile for gestational age, 
denotes a decrease in growth rate that prevents a newborn from obtaining complete growth 
potential (Lackman 2001). It is also the second most antenatal complication in developed 
countries, and increases the risk for morbidity and mortality in newborns (Seeds 1998; Piper 
1996). Further, FGR offspring are at increased risk for later adverse health outcomes including 
heart disease, diabetes and neurodevelopmental disability, with the greatest risk observed in 
those with severe and early-onsetting FGR (Barker 2004). This has led to the notion that the 
intrauterine environment during fetal life can ‘programme’ aberrant organ system development 
leading to adverse outcomes, and there has been a plethora of animal-based studies examining 
mechanisms underlying this relationship (Barker 2004; Zaw 2003).  
Fetal growth restriction is an idiopathic condition, where unknown combinations of maternal and 
fetal factors give rise to incomplete growth, although the majority of FGR is associated with 
placental insufficiency. Placental insufficiency is the inefficiency in the transport of oxygen and 
substrates at the maternal-placental-fetal border and results in a sub-optimal intrauterine 
environment for growth. Despite advances in obstetric care, FGR remains prevalent in developed 
countries where placental insufficiency is the major cause and in developing countries where 
inadequate maternal nutrition plays a greater role (Lumey 1998).  Clinical studies of placental 
insufficiency with FGR demonstrate aberrant placental vascularization (Wang 1992) and 
associated decreases in umbilical blood flow (Roberts 1998), leading to chronic fetal hypoxemia 
as a primary signalling mechanism for the degree of growth restriction (Hracsko 2008).  This has 
led to animal models of placental insufficiency induced by uterine artery ligation, placental 
embolization, or carunclectomy, primarily in sheep and guinea pigs, and leading to FGR with 
variable hypoxemia and nutrient restriction (Belkacemi 2010).  While relevant for representing 
human FGR and developmental programming, these models of placental insufficiency mainly 
target the latter part of pregnancy and limit the ability to study placental responses with the 
artifactual blood flow manipulations. Clinical study of maternal nutrition and FGR is complex, 
and while maternal undernourishment is undoubtedly causative for FGR, this will depend upon 
severity and timing both pre-conception and throughout pregnancy. This has led to animal 
models of maternal nutrient restriction (MNR) induced by global nutrient restriction or protein 
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restriction, pre-conception, peri-conception, and through pregnancy, in a number of animal 
species and leading to variable degrees of FGR (Lumey 1998). These models of MNR are also 
relevant for representing human FGR and developmental programming, and have the added 
advantage of targeting the insult throughout pregnancy paralleling the human situation with 
severe FGR (Low 1992), and of studying placental responses which has increased in the past few 
years (Stevens-Simon 1995). 
These studies of MNR beginning pre-conception in guinea pigs (Sohlstrom 1998; Roberts 2001) 
and early in pregnancy in sheep (Thompson 2011) have generated placentas with reduced surface 
area for exchange, increased barrier thickness, and altered vascular development.   These 
histopathological changes are similar to that seen in human FGR with maternal 
undernourishment (Soothill 1987) and should result in reduced nutrient transport to the fetus 
which has been shown for glucose, amino acids and lipids (Crozier 2009).  However, whether 
oxygen transfer to the fetus is also limited in MNR FGR fetuses either globally or selectively 
with blood flow redistribution (Cox 1988), or is increased with decreased oxygen utilization, has 
yet to be determined.   
In human pregnancies complicated by placental insufficiency with FGR, placental and cord 
blood markers for oxidative stress are increased (Heasman 1999).  Likewise, prenatal hypoxia in 
pregnant guinea pigs leads to increased oxidative stress with lipid peroxidation and DNA 
fragmentation in fetal livers which can be reversed by the antioxidant, N-acetylcysteine (Brodsky 
2004).  As such, chronic hypoxemia in the FGR fetus with placental insufficiency can lead to an 
excess of reactive oxygen species that surpasses antioxidant capacity with damaging effects to 
plasma membranes via lipid peroxidation and to nuclear integrity via DNA fragmentation, which 
may be mechanistic for fetal programming (Brodsky 2004).  Accordingly, it will be important to 
determine the extent to which fetal hypoxia and related oxidative stress also occur with growth 
restriction resulting from the guinea pig model of maternal nutrient restriction, and thereby the 
potential for treatment aimed at decreasing placental-fetal oxidative stress. Overall, it is 
hypothesized that MNR in pregnant guinea pigs will result in fetal tissue growth restriction with 
lowered tissue oxygenation and increased tissue oxidative stress.   
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2.2 HYPOTHESES 
1. Maternal nutrient restriction in guinea pigs beginning pre-conception and continuing 
throughout pregnancy will result in aberrant placental growth and fetal growth restriction in near 
term pups; with the growth restriction being asymmetrical compared to control pups. 
2. Maternal nutrient restriction will alter levels of tissue oxygenation in the near-term guinea pig 
fetus separated into cohorts based on body weight. Compared to control and appropriate for 
gestational age fetuses, MNR-FGR fetuses will have decreased levels of oxygenation resulting in 
increased levels of hypoxia related markers.  
3. Maternal nutrient restriction will alter oxidative stress and antioxidant responses in the near-
term guinea pig fetus separated into cohorts based on body weight. Compared to control and 
appropriate for gestational age fetuses, MNR-FGR fetuses will have increased levels of oxidative 
stress markers resulting in increased levels of antioxidants.  
 
2.3 OBJECTIVES 
1. To apply a MNR (70% of ad lib diet at least 28 days prior to pregnancy and continuing 
throughout and increased to 90% of ad lib diet at mid gestation until near term put-down) diet 
regime to guinea pig sows to create an adverse in utero environment for fetal development, that 
will lead to a degree of growth restriction in guinea pig fetuses, compare growth and placental 
development characteristics, and compare organ system development in relation to asymmetrical  
or symmetrical growth patterns. 
2. To determine differences in oxygenation related protein expression between AGA-Control 
fetuses and MNR-FGR guinea pig fetuses. Specifically, examining Hypoxyprobe 1 (HP-1) 
expression using immunohistochemistry in the placenta and fetal tissues. Also, to substantiate the 
histology using Western Blot techniques in these organs to determine changes in EPO, EPOR, 
and VEGF protein levels. 
3. To determine differences in oxidative stress and stress response related protein expression 
between AGA-Control and MNR-FGR guinea pig fetuses. Specifically, examining MDA and 
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GSSG/GSH expression using a thibarbituric acid reactive substances and cholometric assays, 
respectively, in placental and various fetal tissues. Also, to substantiate the assays using Western 
Blot techniques in these organs to determine changes in Prdx protein levels.  
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3.1 INTRODUCTION 
Fetal growth restriction (FGR) with infants small for their gestational age when born, is a major 
contributor to perinatal morbidity and mortality and for later adverse health outcomes, including 
heart disease, diabetes, and neurodevelopmental disability (Kramer 1990; Piper 1996; Lackman 
2001; Barker 2004; Pryor 1995). This has led to the notion that the intrauterine environment 
during fetal life can “programme” the development of risk factors for these later adverse 
outcomes and an increasing number of human and animal based studies examining mechanisms 
underlying this relationship support this concept (Barker 2004; Godfrey 2000; Armitage 2004; 
Fowden 2006). 
Fetal growth restriction remains prevalent in developed countries where aberrant placental 
development or “placental insufficiency” is a major cause, and in developing countries where 
maternal undernourishment plays a greater role (Jansson 2007; Walker 2007). Clinical study of 
placental insufficiency with FGR demonstrates aberrant placental vascularization (Kingdom 
1997) and associated decreases in umbilical blood flow (Ferrazzi 2000). This has led to animal 
models of placental insufficiency induced by pre-pregnancy uterine carunclectomy (Robinson 
1979), mid-pregnancy exposure to hyperthermic environments (Regnault 1999), or later 
pregnancy uterine artery ligation (UAL)/ablation (Lafeber 1984; Jansson 1990; Detmer 1992; 
Turner 2009), or placental embolization (Murotsuki 1997), primarily in sheep, rats, and guinea 
pigs, and leading to FGR with variable hypoxemia and nutrient restriction. While relevant for 
representing human FGR and developmental programming, these vascular models are variable in 
their timing and severity through pregnancy and can limit the study of placental responses with 
the artifactual blood flow manipulations.  
Clinical study of maternal nutrition and FGR is complex, and while maternal undernourishment 
is undoubtedly causative for FGR, this will depend upon severity and timing pre-conception and 
through pregnancy (Jansson 2007; Walker 2007; Godfrey 1998; Lumey 1998). This has led to 
animal models of maternal nutrient restriction (MNR) induced by global nutrient restriction or 
protein restriction, pre-conception, peri-conception, and through pregnancy, in a number of 
animal species and leading to variable degrees of FGR (Jansson 2007; Sohlstrom 1998; Heasman 
1999; Edwards 2001; Vonnahme 2003; Redmer 2004; MacLaughlin 2005; Belkacemi 2010; Soo 
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2012). These models of MNR are also relevant for representing human FGR and developmental 
programming, and have the advantage of targeting the insult throughout pregnancy analogous to 
the human situation with moderate to severe FGR where intrauterine deprivation is likely to be 
early in onset (Kingdom 1997; MacLaughlin 2005; Sung 1993; Wienerroither 2001). 
Guinea pigs deliver precocial young after a relatively long pregnancy with many developmental 
events occurring during fetal life similar to that in humans (Carter 2007). They have therefore 
proved useful for modeling human FGR with UAL and ablation, but with high fetal loss rates 
and variable occurrence of growth restriction (Lafeber 1984; Jansson 1990; Detmer 1992; Turner 
2009). Moderate MNR in guinea pigs at 70% of an ad libitum diet from 4 weeks pre-conception 
until mid-pregnancy increasing to 90% thereafter, has also been well studied for modeling 
human FGR (Sohlstrom 1998; Roberts 2001; Kind 2003; Kind 2005). Here the capacity of the 
mother to deliver nutrients to the fetus is further impaired since her own fuel reserves are 
depleted prior to conception (Roberts 2001). This should better reflect the human situation with 
undernourishment where pre-pregnant weight is a better determinant of fetal growth and 
development than weight gain during pregnancy (Stevens-Simon 1995) and most women do not 
improve their dietary and lifestyle patterns in pregnancy (Crozier 2009). Study with moderate 
MNR in guinea pigs has shown fetal weights to be decreased as much as 40% in animals near 
term in association with maternal insulin-like growth factor (IGF) and insulin-like growth factor-
binding protein (IGFBP) alterations (Sohlstrom1998; Roberts 2001), and leading to insulin 
resistance in male offspring as also seen in humans born growth restricted (Barker 2004; Kind 
2003). Of note, placental weights are decreased less than fetal weights suggesting compensatory 
growth, but with reduced surface area for nutrient exchange, increased barrier thickness, and 
altered vascular development (Sung 1993; Roberts 2001). These structural alterations in the 
placenta indicate functional impairment and can be seen in human FGR with maternal 
undernourishment (Belkacemi  2010; Aherne  1966) and with pre-eclampsia associated placental 
insufficiency (Aherne 1966; Teasdale 1988). Accordingly, moderate MNR in guinea pigs may 
result in adverse in utero conditions similar to that seen with maternal undernourishment or 
placental insufficiency during human pregnancy and prove useful for modeling FGR in both of 
these. 
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Moderate MNR in guinea pigs has proved useful for inducing FGR and studying maternal, 
placental and fetal growth characteristics, and offspring outcomes (Sohlstrom  1998; Roberts 
2001; Kind 2003; Kind 2006. However, there has been little or no study of breeding and 
pregnancy success, the distribution of fetal weights and means by which FGR might be denoted, 
and the impact on fetal organ weights and blood metabolites. We have therefore studied 
moderate MNR in guinea pigs and report on our breeding and pregnancy success, and 
distribution of fetal weights near term and means for denoting FGR to further characterize the 
utility of this model. We have also determined the impact on fetal crown rump length and organ 
weights, and blood hemoglobin and glucose, hypothesizing that MNR-FGR animals will be lean 
with asymmetrical growth restriction, and polycythemic and hypoglycemic, as often seen in 
human pregnancy with moderate to severe FGR (Kramer 1990; Godfrey 1998; Piorkowska 
2014).             
 
3.2 MATERIALS AND METHODS 
3.2.1 Animal Feeding, Breeding and Pregnancy 
A previously established model of moderate MNR in guinea pigs (Sohlstrom 1998) was used 
with all experimental procedures approved by The University of Western Ontario Animal Use 
Subcommittee and followed the guidelines of the Canadian Council on Animal Care. Nulliparous 
female guinea pigs (Dunkin-Hartley, from Charles River Laboratories, Sherbrooke, Que, 
Canada) were housed in individual cages in a dedicated small animal care facility with a 12 hour 
light/dark cycle and temperature at 25ºC. Animals were fed a guinea pig ration diet (Guinea Pig 
Diet 5025, LabDiet, St. Louis, MO) and after a two week period of acclimatization, daily food 
consumption was monitored and estrous cycles were tracked (Lilley 1997). 
Thirty guinea pig sows were randomly assigned to either a Control group fed ad libitum or an 
MNR group fed 70% of the average food intake per kilogram of body weight of the ad libitum 
fed animals as described by Sohlstrom et al.. (1998). After 4 weeks of adaptation to respective 
feeding regimens, animals were mated. A female found to be in estrous was placed in a cage 
with a male for 48-72 hours and removed when the vaginal membrane was again closed. Animal 
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pregnancies were confirmed by ultrasound 14-21 days later with conception taken to be the day 
prior to membrane closure and thereby day zero of gestation. Animals that were not pregnant 
were rebred at their next estrous cycle. During the first 34 days of pregnancy, the MNR animals 
continued at 70% average food intake of the Control animals per kilogram body weight, and 
from 35 days onward this was increased to 90% average food intake of the Control animals per 
kilogram body weight. Throughout the experiment, daily food intake and body weight of the 
animals were monitored 3-4 times per week and the dietary intake of the MNR animals adjusted 
as needed to maintain their food intake at 70% or 90% of the average food intake per kilogram of 
body weight of the ad libitum fed animals. 
        
3.2.2 Necropsy, Tissue Collection and Blood Analytes 
On day 60-61 of pregnancy (term = ~ 68 days), guinea pig sows were weighed and then sedated 
with an intramuscular injection of Versed (midazolam, 5 mg/kg; Sandoz Canada Inc., 
Boucherville, Que., Canada) and after 10 minutes an intramuscular injection of Vetalar 
(ketamine, 50 mg/kg; Bioniche Animal Health, Belleville, Ont., Canada) and Rompun (xylazine, 
3 mg/kg; Bayer Inc., Toronto, Ont., Canada). A sub-umbilical midline incision was made after 
local infiltration of the abdominal skin with lidocaine (2%; Pfizer Animal Health, Kirkland, 
Que., Canada) followed by uterine incision and delivery of each of the fetuses. Approximately 
1cc of amniotic fluid was obtained from each gestational sac prior to delivery, which was cold-
centrifuged and stored at -80ºC for later analysis. All liveborn fetuses were treated with Vetalar 
as above with body and placental weights then obtained along with crown rump length 
measurements. The number of live and demised fetuses in each uterine horn was also noted. 
Fetuses were considered to be appropriate for gestational age (AGA) if ≥ 80 gms and FGR if < 
80 gms, which is in accord with the criteria we (Piorkowska 2014) and others (Jansson 1990) 
have used for categorizing AGA and FGR fetal weights in guinea pigs near-term. Subsequently, 
only AGA fetuses from Control group litters and FGR fetuses from MNR group litters were 
subjected to full necropsy, with priority given to the medial fetuses in each uterine horn meeting 
these criteria and with no more than three full necropsies per litter to ensure rapid tissue 
collection. Full necropsy consisted of an initial cardiac puncture to obtain ~ 1cc of blood in a 
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heparinized syringe which was then placed on ice until analysis for glucose and hemoglobin 
using an ABL 725 Blood Gas Analyzer (Radiometer, Copenhagen, Denmark). This was followed 
by dissection and weighing of the brain, heart, liver and kidneys, extraction of the gonads for 
determining fetal sex, and extraction of skeletal muscle and peri-renal adipose tissue. These 
organs/tissues along with the placenta were partitioned and both fixed in 4% paraformaldehyde 
and frozen in liquid nitrogen for later analysis.                  
 
3.2.3 Data Acquisition and Statistical Analysis 
Litter size was based on the number of liveborn and demised fetuses noted at necropsy. Fetal 
body weight (gms)/crown rump length (cm) was calculated as a measure of leaness. Overall 
Control and MNR Population characteristics included data from all Control sows and their 
liveborn fetuses, and all MNR sows and their liveborn fetuses, excluding data from animals who 
failed to conceive, and those delivering prior to necropsy. Select AGA-Control and FGR-MNR 
Population characteristics included data from all AGA-Control and FGR-MNR fetuses who were 
liveborn, met the weight criteria noted, and underwent full necropsy. Maternal and fetal 
characteristic findings are presented as group means ± SEM. Overall Control and MNR 
Population characteristics and select AGA-Control and FGR-MNR Population characteristics 
were compared using analysis of variance and non-paired student`s t-test which were also nested 
for litter size (Graphpad Software, San Diego, CA). For all analysis, statistical significance was 
assumed for p<0.05.    
        
3.3 RESULTS 
3.3.1 Breeding and Pregnancy Outcomes 
Of the thirty guinea pig sows, 12 were bred under ad libitum feeding conditions and 18 under 
MNR feeding conditions assuming breeding and pregnancy outcomes would be more adverse for 
the MNR animals and with the smaller litter size reported for MNR pregnancies. Of the 12 
animals bred under ad libitum feeding conditions, three or 25% failed to become pregnant 
44 
 
despite up to four breeding attempts while the remaining animals took 2.4 breeding attempts on 
average to conceive. All nine of these control animals had continuing pregnancies to necropsy at 
60/61 days gestation with 31 liveborn fetuses and one fetal demise which formed the overall 
Control Population. Of the 18 animals bred under MNR feeding conditions, three or 17% failed 
to become pregnant despite up to four breeding attempts while the remaining animals took 2.6 
attempts on average to conceive. However, three of these pregnant MNR sows delivered preterm 
and prior to necropsy at 60/61 days gestation; one at 54 days with 3 fetuses weighing 21, 27, and 
35 gms, one at 56 days with 3 fetuses weighing 50, 60, and 75 gms, and one at 57 days with 4 
fetuses weighing 22, 33, 51, and 66 gms. The remaining 12 MNR animals had continuing 
pregnancies to the time of necropsy with 42 liveborn fetuses and one fetal demise which formed 
the overall MNR Population.  
 
3.3.2 Maternal and Fetal Population Characteristics 
The overall maternal and fetal population characteristics from all ad libitum fed control 
pregnancies and all maternal nutrient restriction pregnancies excepting the three MNR sows 
delivering preterm, are shown in Table 3.1. These data are presented for all fetuses to indicate 
the population variance and allow for comparison with past studies. While maternal weights 
were not different at conception averaging ~ 800 gms, by 60/61 days gestation MNR sows were 
~ 17% lighter at 1046 ± 25 gms than Control sows at 1253 ± 60 gms (p<0.01). Food     
consumption for both animal groups increased through pregnancy as maternal weight increased, 
with the actual food consumption of MNR sows at conception and at 60/61 days gestation being 
~ 65 % and 70 %, respectively, of that consumed by the Control sows. While litter size did not 
differ between the two study groups averaging 3-4, the combined fetal weight per litter was less 
for the MNR animals at 242 ± 21 gms than that of the Control animals at 331 ± 30 gms (p<0.05). 
This was due to fetal weights at necropsy being ~ 28% less in the MNR pregnancies at 69 ± 2 
gms than in the Control pregnancies at 96 ± 2 gms (p<0.01). The 31 liveborn Control fetuses 
ranged in weight from 119 gms to 70 gms with the 50th and 10th percentiles being ~ 96 gms and 
78 gms, respectively, while the 42 liveborn MNR fetuses ranged in weight from 102 to 41 gms 
with the 50th and 10th percentiles being ~ 69 gms and 50 gms, respectively (Figure 3.1). Placental 
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weights were also decreased in the MNR pregnancies by ~ 23% at 5.1 ± 0.2 gms vs that of the 
Control pregnancies at 6.6 ± 0.3 gms (p<0.01). As such, placental weights were decreased less 
than the fetal weights with the placental/fetal weights thereby increased in the MNR pregnancies 
at 7.6 ± 0.3% vs that of the Control pregnancies at 6.8 ± 0.3% (p<0.05). Fetal crown rump 
lengths were also decreased in the MNR pregnancies by ~ 15% at 10.6 ± 0.1 cm vs that of the 
Control pregnancies at 12.3 ± 0.2 cm (p<0.01), but again less than the decrease in fetal weights. 
As such, fetal weight/length as a measure of leaness was also decreased in the MNR pregnancies 
by ~ 15% at 6.4 ± 0.1 gm/cm vs that of the Control pregnancies at 7.8 ± 0.1 gm/cm (p<0.01).     
While MNR fetuses were smaller than Control fetuses on average, there was considerable 
overlap in the population weight distributions as seen in Figure 3.1. This is not surprising since 
litter size, number of fetuses per uterine horn, and fetal position within the horn are all known to 
impact fetal growth (Piorkowska 2014; Turner 2000). We therefore chose to establish a cohort of 
AGA fetuses from the Control group pregnancies and a cohort of FGR fetuses from the MNR 
group pregnancies to allow for more in depth comparative study of growth related parameters. 
As noted, we used 80 gms as our threshold for categorizing AGA and FGR fetal weights at 60/61 
days gestation and determining which Control and MNR fetuses were to be subjected to full 
necropsy with priority given to the medial fetuses in each uterine horn and with no more than 
three full necropsies per litter. This resulted in 20 AGA-Control fetuses and 25 FGR-MNR 
fetuses with the select population characteristics from these animals shown in Table 3.2 and 
Figure 3.1. After examining the gonads for sexing animals, it was determined there were 10 
AGA-Control males and 10 AGA-Control females, and 11 FGR-MNR males and 14 FGR-MNR 
females with no sex differences evident for any of the select fetal population characteristics as 
assessed using analysis of variance. Accordingly, these data are presented for all males and 
females combined as a measure of the population variance and to allow for comparison with past 
studies. While all fetal weights in MNR pregnancies were decreased ~ 28% on average compared 
to Control pregnancies, FGR-MNR fetal weights were decreased by ~ 37% at 64 ± 2 gms 
compared to that of the AGA-Control fetuses at 101 ± 2 gms (p<0.01). FGR-MNR brain weights 
were also decreased, but less so, by ~ 12% at 2.39 ± 0.04 gms vs that of the AGA-Controls at 
2.73 ± 0.05 gms (p<0.01) while FGR-MNR liver weights were markedly decreased by ~ 40% at 
2.8 ± 0.1 gms vs that of the AGA-Controls at 4.7 ±0.2 gms (p<0.01). Accordingly, the brain/fetal 
weights and brain/liver weight ratio as measures of asymmetrical growth were increased 40-50% 
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in the FGR-MNR fetuses at 3.8 ± 0.1% and 0.90 ± 0.03 compared to that of the AGA-Control 
fetuses at 2.7 ± 0.1% and 0.61 ± 0.03, respectively (both p<0.01). FGR-MNR heart weights also 
showed a smaller decrease than the corresponding decrease in fetal weights, by ~ 23% at 0.46 ± 
0.03 gms vs that of AGA-Controls at 0.60 ± 0.03 (p<0.01). As such, the heart/fetal weights was 
increased ~ 22% in the FGR-MNR fetuses at 0.72 ± 0.05% compared to that of the AGA-
Controls at 0.59 ± 0.03% (p<0.05). It is also of note that the threshold of 80 gms here used at 
60/61 days gestation for denoting AGA and FGR fetal weights, is close to the 10th percentile for 
the population weight distribution of the 31 liveborn Control fetuses at ~ 78 gms and thereby in 
accord with the FGR definition often used for human pregnancies (Lackman 2001; Resnik 2014). 
Using this 80 gms threshold, 26 of the 31 Control fetuses or ~ 85% met weight criteria for AGA 
study, while 32 of the 42 MNR fetuses or ~ 75% met weight criteria for FGR study (Figure 3.1).   
                 
3.3.3 Blood Analytes 
Blood glucose and hemoglobin values obtained by cardiac puncture at the time of full necropsy 
in the select AGA-Control and FGR-MNR animals are shown in Table 3.2. FGR-MNR glucose 
values were decreased by ~ 27% at 4.3 ± 0.2 mmol/l vs that of the AGA-Control values at 5.9 ± 
0.4 mmol/l (p<0.01). Conversely, FGR-MNR hemoglobin values were increased by ~ 9% at 15.9 
± 0.2 gm/dl vs that of the AGA-Control values at 14.6 ± 0.4 gm/dl (p<0.05).    
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Table 3.1 Overall Maternal and Fetal Population Characteristics 
 
Control 
(9/31)* 
MNR 
(12/42)* 
Control 
(9/9)* 
MNR 
(12/12)* 
Maternal wt (gms)     
 Conception 816±33 778±9   
 GA 60/61 1253±60 1046±25‡   
Food (gm/day)     
 Conception 38±2 28±1‡   
 GA 60/61 54±4 37±1‡   
Litter size 3.4±0.3 3.5±0.3   
Total litter wt (gms) 331±30 242±21†   
Fetal wt (gms) 96±2 69±2‡ 96±3 71±4‡ 
Placental wt (gms) 6.6±0.3 5.1±0.2‡ 6.5±0.4 5.3±0.2‡ 
Placental/fetal wt (%) 6.8±0.3 7.6±0.3† 6.8±0.4 7.7±0.4 
Crown rump length (cm) 12.3±0.2 10.6±0.1‡ 12.3±0.2 10.8±0.2‡ 
Fetal wt /length (gm/cm) 7.8±0.1 6.4±0.1‡ 7.8±0.2 6.5±0.2‡ 
 
Data presented as means ± SEM; † p < 0.05, ‡ p < 0.01 vs corresponding Control group value 
analyzed using non-paired Student’s t-test, both for the overall populations and nested for litter 
size; * n values were 9 and 12 for maternal and 31 and 42 (overall populations) or 9 and 12 
(nested) for fetal Control and Maternal Nutrient Restricted characteristics, respectively, except 
for litter size where demised fetuses were also counted; MNR = maternal nutrient restriction; GA 
= gestational age. 
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Figure 3.1 Scatter plot showing the fetal weights for all 31 liveborn Control fetuses (open 
circles) and all 42 liveborn maternal nutrient restricted (MNR) fetuses (open triangles) along 
with the 50th and 10th percentiles for each of these cohort populations. Additionally shown are 
the distribution of fetal weights for the select 20 AGA-Control fetuses (closed circles) and 25 
FGR-MNR fetuses (closed triangles).   
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Table 3.2 Select Fetal Population Characteristics 
 
AGA-Control 
(20)* 
FGR-MNR 
(25)* 
AGA-Control 
(9)* 
FGR-MNR 
(11)* 
Fetal wt (gms) 101±2 64±2‡ 99±2 65±3‡ 
Brain wt (gms) 2.73±0.05 2.39±0.04‡ 2.72±0.06 2.42±0.05‡ 
Heart wt (gms) 0.60±0.03 0.46±0.03‡ 0.59±0.04 0.47±0.03† 
Liver wt (gms) 4.7±0.2 2.8±0.1‡ 4.6±0.2 2.9±0.2‡ 
Brain/fetal wt (%) 2.7±0.1 3.8±0.1‡ 2.8±0.1 3.8±0.1‡ 
Brain/liver wt ratio 0.61±0.03 0.90±0.03‡ 0.61±0.03 0.89±0.05‡ 
Heart/fetal wt (%) 0.59±0.03 0.72±0.05† 0.60±0.04 0.73±0.07 
Blood glucose 
(mmol/l) 
5.9±0.4 4.3±0.2‡ 5.9±0.5 4.4±0.3† 
Blood Hb (gm/dl) 14.6±0.4 15.9±0.2† 14.6±0.4 15.8±0.3† 
 
Data presented as means ± SEM; † p < 0.05, ‡ p < 0.01vs corresponding AGA-Control group 
value analyzed using non-paired Student’s t-test, both for the select populations and nested for 
litter size; *n values were 20 and 25 (select populations) or 9 and 11 (nested) for fetal AGA-
Control and FGR-MNR characteristics, respectively, except for blood glucose and hemoglobin 
where these were instead 15 and 19 (select populations) or 8 and 11 (nested), respectively; AGA 
= appropriate for gestational age, FGR = fetal growth restricted, MNR = maternal nutrient 
restricted, Hb = hemoglobin. 
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3.4 DISCUSSION 
In the present study, we have characterized pregnancy outcomes in guinea pigs subjected to 
moderate nutrient restriction both before and through pregnancy as a useful model for inducing 
FGR with similarities to that seen in humans with maternal undernourishment and idiopathic 
placental insufficiency. Both Control and MNR sows had comparable fertility with successful 
pregnancies in ~ 80% of the animals, and requiring ~ 2.5 breeding attempts on average. Maternal 
age did not have an impact on pregnancy success, although no animals were bred prior to four 
months which is presumed adulthood for guinea pigs. However, only two animals, one control 
and one MNR, became pregnant with a conception weight less than 750 grams, suggesting an 
effect of maternal weight on pregnancy success which has also been noted in guinea pig studies 
with UAL (Detmer 1992). Since MNR animals took anywhere from 1 to 4 breeding attempts 
before becoming pregnant, the duration of preconception undernourishment was also impacted, 
and could be from 4 weeks up to 12 weeks. However, there was no evidence that an increased 
duration of MNR here impacted maternal weight at conception, litter size, fetal weights, or the 
risk of preterm delivery. As such, 4 weeks of moderate MNR prior to breeding in guinea pigs is 
sufficient for inducing FGR, while longer periods of moderate MNR as studied did not appear to 
worsen pregnancy outcomes. The fetal demise rate was low at 1 in 32 control fetuses and 1 in 43 
MNR fetuses and much lower than that reported with uterine artery ligation (UAL) or ablation 
models, where demise rates upwards of 70 – 80% have been noted (Lafeber 1964; Turner 2009). 
This undoubtedly reflects the insidious nature of MNR-FGR with early and gradual growth 
restriction in response and matched to early nutritional deficiency (Godfrey 1998; Sohlstrom 
1998; Redmer 2004; Belkacemi 2010; Roberts 2001) versus the relatively abrupt nature of 
UAL/ablation-FGR with normal fetal growth then a sudden reduction in placental blood flow 
and a variable mismatch between metabolic needs and nutrient delivery. However, 3 of 15 MNR 
sows delivered preterm and prior to the planned necropsy at 60/61 days gestation, with 2 of these 
mothers having the lowest maternal weights adjusted for gestational age and with low fetal 
weights at delivery. This finding has also been reported in guinea pigs by Kind et al.. (2003) with 
moderate MNR-FGR and by Palliser et al.. with uterine artery ablation-FGR and likely involves 
FGR associated increases in inflammatory processes with a shift in prostaglandin production 
over metabolism (Palliser 2014). In the present study the overall fetal loss rate whether from 
demise or preterm birth was therefore 1 of 32 or 3% for the control group and 11 of 53 or 20% 
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for the MNR group which is still considerably less than that reported for UAL/ablation models as 
noted. Additionally, some of the MNR fetuses delivering preterm were liveborn and did survive 
offering the opportunity for study of longer term outcomes with FGR and preterm birth which is 
also well known to occur in humans (Lackman 2001). 
Moderate MNR at 70% of the ad libitum diet beginning at least 4 weeks pre-pregnancy and 
increasing to 90% of the ad libitum diet at mid-pregnancy, resulted in a decrease in maternal 
weights by ~ 5% and 17% at conception and 60/61 days gestation, respectively.  This decrease in 
maternal weight is somewhat less than that previously reported by Sohlstrom et al. and Roberts 
et al. at ~ 10% and 28% using the same moderate MNR dietary regime, but their animals were 
smaller to begin with averaging 550 gms at mating and likely indicating strain differences to the 
guinea pigs presently used.  Likewise, the actual decrease in food consumption at ~ 26% and 
32% in MNR sows at conception and 60/61 days gestation, respectively, was somewhat less than 
that reported by Roberts et al. at ~ 37% and 36% in their MNR sows which may be attributable 
to their smaller animals. Interestingly, litter size was unchanged in the present study which 
differs from the findings of Sohlstrom et al. where moderate MNR decreased litter number from 
~3 to 2 when necropsied at 60 days. This may again be attributable to their smaller animals and 
indicates that moderate MNR as outlined may adversely affect early embryonic/fetal 
developmental events leading to failure pending initial maternal weight and thereby fuel reserves 
for mobilization (Godfrey 1998; Heasman 1999; Belkacemi 2010; Kramer 1987; Abrams 1991). 
Fetal weights were decreased by 28% on average for all MNR pregnancies necropsied near term 
at 60/61 days gestation, which not surprisingly is less than that reported by Sohlstrom et al. at ~ 
40% given their smaller animals. This again emphasizes the importance of maternal pre-
pregnancy weight as a measure of nutritional reserve for fetal/placental growth and development 
when nutrient intake and thereby weight gain become compromised during pregnancy (Godfrey 
1998; Heasman 1999; Redmer 2004; Belkacemi 2010; Kramer 1987; Abrams 1991).  Of interest, 
the fetal weight variation in these animal cohort populations can be assessed using the coefficient 
of variation (CV) and calculated as the standard deviation divided by the population mean. In the 
present study and that of Sohlstrom et al., this was comparable at ~ 12% for all fetal weights 
from control animals fed ad libitum, and somewhat less than that at ~ 18% for control fetuses in 
the untreated uterine horn of animals subjected to UAL/ablation and suggesting an impact of the 
surgical procedure here. In both the present and Sohlstrom studies, the CV for all fetal weights 
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from MNR animals was substantially increased at ~ 22%, and now similar to that in the treated 
horn of UAL/ablation animals (Turner 2009) and indicating an increase in growth variance with 
these animal models for inducing FGR. Placental weights were decreased by 23% on average for 
all MNR pregnancies and less than the corresponding decrease in fetal weights thereby resulting 
in an ~ 12% increase in the placental/fetal weight ratio which is similar to that noted by 
Sohlstrom et al. with moderate MNR (Sohlstrom 1998). Notably this increase in placental to 
bodyweight ratio is also seen in human pregnancies leading to FGR both with maternal 
undernourishment and presumed placental insufficiency and taken to indicate a degree of 
compensatory growth by the placenta to minimize FGR (Jansson 2007; Kingdom 1997; Godfrey 
1998; Lumey 1998; Redmer 2004; Belkacemi 2010; Lackman 2001). Fetal crown rump lengths 
were also decreased in MNR pregnancies, but again less than the corresponding decrease in fetal 
weights resulting in an ~ 15% decrease in fetal weight/length and indicating leaner animals 
which was also noted by Kind et al. with moderate MNR in guinea pigs (Kind 2005). Likewise, 
leanness is often a characteristic in human infants with moderate growth restriction whether 
resulting from maternal undernourishment or idiopathic placental insufficiency (Godfrey 1998; 
Kramer 1990; Fall 1999).  
We set a threshold of ≥ 80 gms or < 80 gms for categorizing AGA-Control and FGR-MNR fetal 
cohorts, respectively, which is in accord with the criteria we (Piorkowska 2014) and others 
(Jansson 1990) have used for categorizing AGA and FGR fetal weights in guinea pigs near- 
term. Of note, this threshold of 80 gms was close to the 10th percentile for the population weight 
distribution of the liveborn Control fetuses at ~ 78 gms further justifying its use. We did not 
include the requirement for an increased brain/liver weight ratio for the FGR cohort as in other 
studies with UAL/ablation (Detmer 1992; Piorkowska 2014), since we did not want to presume 
how this would be impacted by MNR induced FGR. This establishment of AGA-Control and 
FGR-MNR cohort groups has the advantage of avoiding any confounding effects of 
tissue/metabolite study in AGA fetuses from MNR pregnancies and FGR fetuses from Control 
pregnancies; further reduces the fetal weight variation with the CV in these cohort groups now 
decreased to ~ 9% and 16%, respectively; and better reflects the human situation where AGA 
and FGR birth weight distributions are separate and often delineated by the 10th percentile 
adjusted for gestational age (Resnik 2014; Lackman 2001). As expected, the decrease in FGR-
MNR fetal weights vs the AGA-Controls at ~ 37% was considerably more than the decrease in 
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overall MNR fetal weights versus the overall Controls at ~ 28%. Moreover, growth restriction in 
MNR pregnancies was asymmetrical with the mean decrease in liver weights at ~ 40% much 
more than that of the brain and heart at ~ 12% and 23%, respectively. Accordingly, the 
brain/liver weight ratio was increased by almost 50% in FGR-MNR fetuses which was similar to 
that noted by Kind et al. in their MNR fetuses, while the heart/fetal weight ratio was increased by 
almost 25% in FGR-MNR fetuses (Kind 2005). This asymmetrical growth restriction is likely 
due in part to chronic blood flow redistribution favouring the vital organs, including the brain 
and heart at the expense of the liver and carcass tissues (Richardson 1989), and altered 
gluconeogenic capacity and/or protein synthesis with a greater impact on the liver and muscle 
than other tissues (Thorn 2009). Of note, asymmetrical FGR is also seen in guinea pigs with mid-
gestation UAL/ablation (Lafeber 1984; Turner 2009; Piorkowska 2014), and in humans with 
placental insufficiency leading to growth restriction (Resnik 2014; Kramer 1987; Abrams 1991), 
with both of these likely to involve chronic fetal hypoxemia as a primary signaling mechanism 
(Lafeber 1984; Turner 2009; Lackman 2001). It is also of note that MNR induced FGR in sheep 
leads to ventricular hypertrophy which is thought to reflect increased afterload due to increased 
placental vascular resistance (Vonnahme 2003). Accordingly, the present increase in heart/fetal 
weight ratio in FGR-MNR fetuses may also indicate a degree of ventricular hypertrophy 
secondary to increased placental vascular resistance. This is in fact likely with the altered 
vascular development and structural changes reported in the placenta of guinea pigs subjected to 
moderate MNR (Roberts 2001).  
Blood sampling at necropsy revealed FGR-MNR fetuses to be relatively polycythemic and 
hypoglycemic compared to AGA-Control fetuses. Likewise, an increase in hemoglobin and 
decrease in glucose are well associated with FGR in several animal models and human clinical 
studies. These include those in guinea pigs after UAL (Lafeber 1984; Jansson 1990) and sheep 
after MNR (Vonnahme 2003) or carunclectomy (Robinson 1979), and in human pregnancies 
with suspected placental insufficiency subjected to cordocentesis (Soothill 1987; Cox 1988; 
Economides 1989). These studies indicate that the basis for the hypoglycemia with FGR is likely 
multifactorial including lowered maternal glucose (Vonnahme 2003), reduced placental glucose 
transport and/or fetal glucose delivery (Robinson 1979; Lafeber 1984; Economides 1989), and 
reduced fetal gluconeogenesis (Jansson 1990), and dependent on the underlying etiology with 
maternal hypoglycemia likely to play a greater role with undernourishment. However, the basis 
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for the polycythemia with FGR is likely singularly due to stimulated erythropoiesis attempting to 
maintain oxygen carrying capacity in response to chronic hypoxemia as variably shown in these 
studies(Robinson 1979; Lafeber 1984; Soothill 1987; Cox 1988; Economides 1989).  
Moderate MNR in guinea pigs has been well studied for modeling human FGR including 
maternal, placental, and fetal growth characteristics, associated IGF and IGFBP alterations, and 
mechanisms for programming longer-term adverse outcomes in offspring (Sohlstrom 1998; 
Roberts 2001; Kind 2003; Kind 2005). We now add to these findings further characterizing 
breeding and pregnancy success in MNR animals and showing low fetal demise rates in contrast 
to that seen with uterine ligation/ablation models (Lafeber 1984; Turner 2009), albeit with 
increased preterm delivery as is seen with FGR in humans (Lackman 2001). Comparative study 
to that using the same moderate MNR dietary regime and impact on maternal/fetal weights and 
litter size (Sohlstrom 1998; Roberts 2001) highlight the importance of maternal pre-pregnancy 
weight as a measure of nutritional reserve for fetal/placental growth when nutrient intake is 
compromised during pregnancy (Godfrey 1998; Heasman 1999; Redmer 2004; Belkacemi 2010; 
Kramer 1987; Abrams 1991). As previously shown (Sohlstrom 1998; Kind 2005), we confirm 
that MNR fetuses are leaner and have increased placental/fetal weight ratios as is often seen in 
human infants with moderate growth restriction whether resulting from maternal 
undernourishment or placental insufficiency (Kramer 1990; Godfrey 1998; Lumey 1998; 
Belkacemi 2010; Lackman 2001; Fall 1999). We also provide justification for using a fetal 
weight threshold for categorizing AGA-Control and FGR-MNR cohorts which ~ the 10th 
percentile in our ad libitum fed animals, and serves to reduce the population variance in these 
groups. Of note, these FGR-MNR fetuses show asymmetrical growth restriction, and are 
polycythemic and hypoglycemic which are well associated with moderate growth restriction 
during human pregnancy (Kramer 1990; Resnk 2014; Kramer 1991; Abrams 1991; Soothill 
1987; Cox 1988; Economides1989). These findings along with the altered vascular development 
and structural changes reported in the placenta of guinea pigs subjected to moderate MNR 
(Roberts 2001), also raise the possibility of chronic hypoxemia as a primary signaling 
mechanism for the decreased fetal growth in these pregnancies which requires further study. As 
such, the present and past studies of moderate MNR in guinea pigs (Sohlstrom 1998; Roberts 
2001; Kind 2003; Kind 2005) support the utility of this model for inducing FGR with many 
similarities to that in humans with moderate growth restriction whether resulting from maternal 
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undernourishment or placental insufficiency. While there will be differences in FGR outcomes 
resulting from maternal undernourishment vs placental insufficiency including the impact on 
fetal gene expression (Nüsken 2011), it is likely that these will also depend on the timing, 
severity and duration of the nutrient deprivation as much as the cause (Heasman 1999; McMillen 
2001).  
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CHAPTER 4 
MATERNAL NUTRIENT RESTRICTION IN GUINEA PIGS LEADS TO FETAL 
GROWTH RESTRICTION WITH EVIDENCE FOR CHRONIC HYPOXIA 
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4.1 INTRODUCTION 
Fetal growth restriction (FGR) with infants small for their gestational age when born, is an 
important risk factor for later adverse health outcomes, including heart disease, diabetes, and 
neurodevelopmental disability, with the greatest risk observed in those with more severe and 
early-onsetting FGR (Barker 2004; Sung 1993). This has led to the notion that the intrauterine 
environment during fetal life can “programme” the development of risk factors for these later 
adverse outcomes and extensive animal-based study examining mechanisms underlying this 
relationship (Barker 2004; Armitage 2004; Fowden 2006). 
Fetal growth is dependent on maternal nourishment and placental development which impact 
substrate availability for regulating fetal growth processes with maternal undernourishment and 
idiopathic placental insufficiency thereby primary causations for FGR (Jansson 2007; Resnik 
2014). Clinical study of placental insufficiency-related FGR demonstrates aberrant placental 
vascularization and decreases in umbilical blood flow (Kingdom 1997; Ferrazzi 2000), leading to 
chronic fetal hypoxemia as a primary signaling mechanism for the degree of growth restriction 
(Soothill 1987; Lackman 2001). This has led to animal models of placental insufficiency induced 
by restricting placental blood flow, mostly through the latter part of pregnancy, and leading to 
FGR with variable hypoxemia and nutrient restriction (Jansson 1986; Murotsuki 1997; Turner 
2009). Clinical study in populations subjected to food restriction (Lumey 1998) and in mothers 
deemed underweight (Godfrey 1998; Sebire 2001; Ehrenberg 2003) support the notion that 
maternal undernourishment is undoubtedly causative for FGR dependent upon severity and 
timing pre-conception and through pregnancy. This has led to animal models of maternal nutrient 
restriction (MNR) induced by global nutrient restriction or protein restriction, pre-conception, 
peri-conception, and through pregnancy, and leading to variable degrees of FGR (Jansson 2007; 
Sohlstrom 1998; Roberts 2001; Vonnahme 2003; Redmer 2004; Belkacemi 2010). MNR pre-
conception continuing through pregnancy also parallels the human situation with moderate to 
severe FGR where intrauterine deprivation is likely to be early in onset (Sung 1993; Resnik 
2014; Kingdom 1997). These studies in guinea pigs and sheep have generated placentas with 
reduced surface area for nutrient exchange, increased barrier thickness, and altered vascular 
development (Roberts 2001; Redmer 2004; Belkacemi 2010), which have also been reported in 
human FGR with maternal undernourishment (Aherne 1966). This should result in reduced 
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nutrient transport to the fetus which has been shown for glucose, amino acids, and lipids 
(Belkacemi 2010; Gaccioli 2013). However, whether fetal oxygenation is also limited as a 
signaling mechanism, or is even increased with decreased utilization, has yet to be determined. 
Guinea pigs deliver precocial young after a relatively long pregnancy with many developmental 
events occurring during fetal life similar to that in humans (Carter 2007). Moderate MNR in 
guinea pigs at 70% of an ad libitum diet from 4 weeks pre-conception until mid-pregnancy 
increasing to 90% thereafter, has therefore been well studied for modeling human FGR and 
longer term outcomes (Sohlstrom 1998; Roberts 2001; Kind 2005). Here the capacity of the 
mother to deliver nutrients to the fetus is further impaired since her own fuel reserves are 
depleted prior to conception (Sohlstrom 1998; Roberts 2001) and reflects the human situation 
where pre-pregnant weight is a better determinant of fetal growth and development than weight 
gain during pregnancy (Stevens-Simon 1995). This study has shown fetal weights to be 
decreased as much as 40% in animals near term, but with placental weights less decreased 
(Sohlstrom 1998; Roberts 2001) suggesting compensatory growth as often seen in human FGR 
infants (Lackman 2001; Belkacemi 2010). Additionally, these MNR-FGR fetuses have 
asymmetrical organ growth (Kind 2005), and as outlined in Chapter 3, are polycythemic and 
hypoglycemic (Table 3.2) which are also well associated with FGR in humans (Soothill 1987). 
These findings along with the structural changes and altered vascular development in the 
placentas of these animals (Roberts 2001), also make it likely that chronic hypoxemia is 
occurring as a primary signaling mechanism for the decreased fetal growth in these pregnancies.  
In the present study, we have determined the extent to which moderate MNR in guinea pigs as a 
causative factor for FGR also impacts markers for tissue hypoxia to test the hypothesis that these 
will be increased further implicating chronic hypoxia as a primary signaling mechanism here. 
Protein levels for erythropoietin (EPO) and its receptor (EPOR) have been assessed since these 
are up-regulated to promote erythropoiesis in response to systemic hypoxia, and protein levels 
for vascular endothelial growth factor (VEGF) have been assessed since this is up-regulated to 
promote angiogenesis in response to local tissue hypoxia (Semenza 2009). Immunoreactivity for 
hypoxyprobe-1 (HP-1), a pimonidazole hydrochloride that is reduced in hypoxic cells, has 
additionally been assessed as a widely used marker of tissue hypoxia (Raleigh 1999; Lee 2001). 
Moreover, these hypoxic markers have been assessed in the fetal liver and kidney as well as the 
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placenta, in both male and female fetuses, given the likelihood of tissue and/or sex specific 
changes with differences in production rates for these proteins and basal oxygenation.                
         
4.2 MATERIALS AND METHODS\ 
 
4.2.1 Animal Cohorts and Tissue Collection 
A previously established model of moderate MNR in guinea pigs (Sohlstrom 1998; Roberts 
2001; Kind 2005) was used with all experimental procedures approved by The University of 
Western Ontario Animal Use Subcommittee and followed the guidelines of the Canadian 
Council on Animal Care. Animal feeding, breeding and pregnancy outcomes have previously 
been reported in Chapter 3. Briefly, nulliparous female guinea pigs (Dunkin-Hartley, from 
Charles River Laboratories, Sherbrooke, Que, Canada) were fed a guinea pig ration diet (Guinea 
Pig Diet 5025, LabDiet, St. Louis, MO) and after a two week period of acclimatization, daily 
food consumption was monitored and estrous cycles were tracked.  
Guinea pig sows were assigned to either a Control group fed ad libitum or an MNR group fed 
70% of the average food intake per kilogram of body weight of the ad libitum fed animals. After 
4 weeks of adaptation to respective feeding regimens, animals were mated. During the first 34 
days of pregnancy, the MNR animals continued at 70% average food intake of the Control 
animals per kilogram body weight, and from 35 days onward this was increased to 90% average 
food intake of the Control animals per kilogram body weight. 
On day 60-61 of pregnancy (term = ~ 68 days), the hypoxia marker pimonidazole hydrochloride 
(Hypoxyprobe-1, 60 mg/kg, Chemicon, Temecula, CA) was injected intraperitoneally into 
Control and MNR sows and allowed to circulate for 90 minutes. Animals were then sedated 
followed by laparotomy and delivery of each of the fetuses. Body and placental weights were 
obtained from all liveborn fetuses along with crown rump length measurements. Fetuses were 
considered to be appropriate for gestational age (AGA) if ≥ 80 gms and FGR if < 80 gms, which 
is in accord with the criteria we (Piorkowska 2014) and others (Jansson 1990) have used for 
categorizing AGA and FGR fetal weights in guinea pigs near-term. Moreover, this threshold of 
80 gms is close to the 10th percentile for the population weight distribution of the liveborn 
Control fetuses at ~ 78 gms and thereby in accord with the FGR definition often used for human 
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pregnancies (Resnik 2014, Lackman 2001). Subsequently, only AGA fetuses from Control group 
litters and FGR fetuses from MNR group litters were subjected to full necropsy which consisted 
of an initial cardiac puncture to obtain ~ 1cc of blood for glucose and hemoglobin analysis using 
an ABL 725 Blood Gas Analyzer (Radiometer, Copenhagen, Denmark). This was followed by 
dissection and weighing of the brain, heart, liver and kidneys, extraction of the gonads for 
determining fetal sex, and extraction of skeletal muscle and peri-renal adipose tissue. These 
organs/tissues along with the placenta were partitioned and both frozen in liquid nitrogen and 
fixed in 4% paraformaldehyde for later analysis. Liver (right lobe), kidney and placental tissues 
were assessed for hypoxia markers with that for protein analysis stored at -80⁰C until protein 
quantification, and that for histology kept in 4% paraformaldehyde for 72 hours, then washed in 
phosphate buffered saline (PBS) daily for 3 days, and then placed in 70% ethanol for 7-14 days, 
prior to blocking in paraffin. Tissue sections were subsequently cut at 5um on a rotary 
microtome and mounted on superfrost Plus slides (VWR Scientific, West Chester, PA). 
Sixteen AGA-Control fetuses (8 male and 8 female) and 16 FGR-MNR fetuses (8 male and 8 
female) were selected for hypoxic tissue analysis. These animals were representative of the mean 
fetal weights for their respective cohort groups and were from either the first or second medial 
position in the uterine horn, and with no more than one male and one female fetus from each 
litter.                   
 
4.2.2 EPO, EPOR and VEGF Protein Analysis 
Approximately 30-50 mg of liver, kidney or placental tissue were homogenized with 10uL of 
RIPA buffer (50mM Tris-HCL, pH 7.4, 150mM NaCl, 1mM EDTA, 1% Nonidet P40, 0.25% 
C24H39Na04, supplemented with 1mM NaV, 50mM NaF, and 25nM C3H7O6PNa2.XH2O) per 
mg of kidney and placental tissue and 15uL of RIPA buffer per mg of liver tissue in the presence 
of a protease inhibitor (Roche, Mississauga, Ontario, Canada). Homogenates were sonicated 
using two pulses at 30% amplitude and centrifuged at 15000g for 10 minutes at 4⁰C, with 300uL 
of the supernatant then extracted and retained as the total protein fraction. Equal amounts of the 
tissue extracts were normalized by colorimetric BCA Protein Assay (Pierce Corp., Madison, 
WI). Samples were stored at -20⁰C until protein analysis. 
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The extracted protein samples were used to prepare loading samples for gel electrophoresis at a 
voltage of 180V in gradient NuPAGE 4-12% Bis-Tris polyacrylamide gels (Invitrogen Life 
Technologies Co., Burlington ON, Canada) for one hour. AGA-Control and FGR-MNR male 
samples were loaded and run together on one gel, while AGA-Control and FGR-MNR female 
samples were run together on a separate gel and each tissue analyzed was run on a separate gel. 
This was followed by a gel transfer onto a polyvinyliden difluoride membrane (Millipore, 
Etobicoe, ON, Canada) at a voltage of 100V for two hours. Following transfer, membranes were 
thoroughly washed and then blocked for two hours with 5% albumin in Tris-buffered saline 
containing 0.1% Tween (TBST). Membranes were then incubated overnight at 4⁰C using 
primary antibodies specific for the protein targets, EPO (1:500, Novus Biologicals, Oakville ON, 
Canada), EPOR (1:500, Santa Cruz Biotechnology Inc. Dallas, TX) and VEGF (1:500 for liver 
and kidney; 1:300 for placenta, Santa Cruz Biotechnology Inc.) diluted in 5% milk 1xTris-
buffered saline-Tween 20 buffer. The following day, membranes were washed with PBS and 
then probed for one hour at room temperature with Horseradish peroxidase conjugated donkey 
anti-rabbit IgG (1:10000, Jackson ImmunoResearch Laboratories, West Grove, PA), diluted in 
5% milk. Immunoreactive bands were visualized using a Luminata Forte Western HRP enhanced 
chemiluminesence detection system (Thermo Scientific, Nepean, ON, Canada) and VersaDoc 
Imaging System (BioRad Laboratories, Mississauga, ON, Canada). Densitometry analysis of 
protein bands was performed using ImageLab with signal saturation software (BioRad 
Laboratories) normalized to the protein levels of β-actin as a loading control. 
 
4.2.3 Hypoxyprobe 1 Immunohistochemistry 
Hypoxyprobe-1 (HP-1) immunoreactivity was assessed by avidin-biotin complex enhanced 
immunohistochemistry (Vectastain; Vector Laboratories, Burlingame, CA). Tissue sections were 
deparaffinized in 3 sequential xylene baths for 5 minutes and immediately rehydrated in baths of 
100% (2x2min), 90% (2x2min), and 70% (1x2min) ethanol and placed under running tap water 
for 5 minutes.  After a PBS rinse, slides were incubated in boiling 10mM citrate buffer (pH 6.0) 
in a vegetable steamer for 20 minutes, followed by 5 minutes in boiling H2O to enhance antigen 
target retrieval. After cooling, endogenous peroxidase was quenched by a 1% hydrogen peroxide 
bath for 10 minutes. Endogenous biotin activity was then blocked using an avidin and biotin kit 
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(Vector Laboratories) for 40 minutes followed by Background SNIPER (Biocare Medical, 
Concord, CA) for 5 minutes to reduce non-specific binding. 
Tissue sections were incubated overnight with primary antibody, mouse-anti rabbit monoclonal 
hypoxyprobe-1, at 1:400 (liver and placenta) or 1:200 (kidney), (Hypoxyprobe Inc, Burlington, 
MA) diluted with Universal Antibody Dilutent (Dako Canada, Burlington, ON, Canada) at room 
temperature in a covered humidity chamber. The following day sections were rinsed and then 
incubated with secondary antibody (biotinylated goat anti-rabbit immunoglobulin G, 1:200; 
Vector Laboratories) at room temperature for 40 minutes in a covered humidity chamber and 
again rinsed. Sections were then incubated with an avidin-biotin complex (ABC) solution 
(avidin-biotin peroxidase complex 1:50, Vector Laboratories) at room temperature for 30 
minutes in a covered humidity chamber. The bound antibody was visualized with Cardassian 
D.A.B. (3,3-diaminobenzadine) chromogen (Biocare Medical) at room temperature for 2 
minutes. Sections were again rinsed with PBS and then counterstained by immersing in 1:2 
Harris` Hematoxylin (Fisher Scientific, Ottawa, Ontario) for 30 seconds and immediately rinsing 
in running tap water until clear. Lastly, sections were rinsed with PBS and then dehydrated in 
alcohol baths of increasing concentration (70% 2x30 sec; 90% 2x1 min; 100% 2x3 min) 
followed by 3x5 minute rinses in xylene before being cover slipped using Permount. Slides were 
left 24 hours to dry in a fume hood before being visualized. All slides for the primary antibody 
were stained on the same day using the same solutions to minimize variation in intensity of stain. 
Negative controls included substitution of the primary antiserum with nonimmune serum to rule 
out nonspecific binding and confirmed absence of staining.            
Hypoxyprobe-1 IR was imaged in 4 randomly selected high power fields (HPF, 20X 
magnification) from comparable areas in the liver, kidney and placenta for each of the AGA-
Control and FGR-MNR fetuses using a Zeiss upright light microscope (Carl Zeiss Microimagin, 
Thornwood, NY). The percentage area of positive cell staining (brown staining) was determined 
using Image Pro Premier 9.2 software (Meyer Instruments, Houston, TX). To insure consistency 
and impartial evaluation, a threshold macro was set up for each of the three tissues examined 
based on testing of a random sample of images including screening against negative controls to 
select and count only cell bodies deemed to be positively stained. While a different threshold 
macro was thereby established for each of the three tissues, once set, the same macro was used 
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for each image of that tissue. The scoring of images for a given tissue was completed within the 
same day and all analyses were performed with the investigator blinded to the animal cohort 
grouping. Hypoxia intensity was expressed as the percentage area of positive cell staining 
meaned for the 4 HPFs for each of the 3 tissues examined for each of the AGA-Control and 
FGR-MNR fetuses.                 
           
4.2.4 Data Acquisition and Statistical Analysis 
Overall Control and MNR Population characteristics included data from all Control sows and 
their liveborn fetuses, and all MNR sows and their liveborn fetuses undergoing necropsy at 60/61 
days gestation. Select AGA-Control and FGR-MNR Population characteristics included data 
from all AGA-Control and FGR-MNR fetuses who were liveborn, met the weight criteria noted, 
and underwent full necropsy. Maternal and fetal characteristic findings, hypoxia-related protein 
levels, and HP-1 immunoreactvity are presented as group means ± SEM. Control and MNR 
Population characteristics, and AGA-Control and FGR-MNR Population characteristics, 
hypoxia-related protein levels, and HP-1 immunoreactvity were compared using non-paired 
student`s t-test (Graphpad Software, San Diego, CA). For all analysis, statistical significance was 
assumed for p<0.05. 
 
4.3 RESULTS 
4.3.1 Fetal Population Characteristics 
As previously outlined in Chapter 3, nine control animals and 12 MNR animals had continuing 
pregnancies out to necropsy at 60/61 days gestation with 31 and 42 liveborn fetuses, 
respectively, which formed the overall Control and MNR Populations. The fetal growth 
characteristics from these animals are shown in Table 4.1 and have previously been reported in 
Chapter 3. Briefly, fetal weights were ~ 28% less in the MNR pregnancies than in the Control 
pregnancies (p<0.001). Placental weights were also decreased in the MNR pregnancies by ~ 23% 
(p<0.01), but less so than the fetal weights and accordingly the placental/fetal weight ratios were 
increased by ~ 12% (p<0.05). Fetal crown rump lengths were also decreased in the MNR 
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pregnancies by ~ 15% (p<0.001), but again less than the decrease in fetal weights such that fetal 
weight/length as a measure of leaness was also decreased by ~ 15% (p<0.001). 
As noted, we used 80 gms as our threshold for categorizing AGA and FGR fetal weights and 
determining which Control and MNR fetuses were to be subjected to full necropsy. This resulted 
in 20 AGA-Control fetuses and 25 FGR-MNR fetuses with the growth characteristics from these 
select animals shown in Table 4.2, which have also been outlined in Chapter 3 results. Briefly, 
FGR-MNR fetal weights were decreased by ~ 37% compared to that of the AGA-Control fetuses 
(p<0.001). FGR-MNR brain weights were also decreased, but less so, by ~ 12% (p<0.001) while 
FGR-MNR liver weights were markedly decreased by ~ 40% (p<0.001). Accordingly, the 
brain/liver weight ratio as a measure of asymmetrical growth was increased almost 50% in the 
FGR-MNR fetuses compared to that of the AGA-Control fetuses (p<0.001). FGR-MNR glucose 
values were decreased by ~ 27% (p<0.01) while FGR-MNR hemoglobin values were increased 
by ~ 9% (p<0.05) vs that of the AGA-Control values.    
 
4.3.2 EPO, EPOR, and VEGF Protein Levels 
EPO, EPOR, and VEGF protein levels normalized to the protein levels of β-actin are presented 
as the mean change for that of the FGR-MNR fetuses from that of the AGA-Control fetuses. For 
all 16 FGR-MNR animals, EPO was increased in the liver ~ 1.5 fold, in the kidney ~ 1.6 fold, 
and in the placenta ~ 1.4 fold when compared to that of the 16 AGA-Control animals (all 
p<0.01) (Figure 4.1). However, this was largely due to even greater fold increases in the FGR-
MNR females (all p<0.01 or p<0.001) with little change in the FGR-MNR males (all NS). EPOR 
showed no overall change for any of the tissues studied when assessed for all FGR-MNR 
animals (Figure 4.2). However, sex differences were again evident for the liver with FGR-MNR 
females showing an ~ 1.7 fold increase (p<0.01), while FGR-MNR males showed an ~ 50% 
decrease (p<0.05) from respective AGA-Controls. VEGF was increased in the liver ~ 1.5 fold 
(p<0.05) and in the placenta ~ 1.7 fold (p<0.05) when assessed for all FGR-MNR animals 
(Figure 4.3); but this again involved sex differences with that for the liver largely due to an even 
greater fold increase in FGR-MNR females (p<0.01) and that for the placenta largely due to an 
even greater fold increase in FGR-MNR males (p<0.05). 
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4.3.3 Hypoxyprobe-1 Immunoreactivity  
Pimonidazole hydrochloride crosses the placenta and is reduced by nitroreductases in relatively 
hypoxic cells in the fetus (pO2 < 10 mmHg) to form covalent protein adducts which can then be 
detected immunohistochemically using the Hypoxyprobe-1 kit (Raleigh 1999; Lee 2001). 
Accordingly, immunostaining for Hypoxyprobe-1 can be used to assess differences in local 
tissue hypoxia as we have done in the present study in the fetal liver, kidney and placenta. Since 
the EPO, EPOR, and VEGF protein changes were primarily observed between the FGR-MNR 
and AGA-Control female groups, the Hypoxyprobe-1 study was limited to these animals. 
 
Representative images are shown in Figure 4.4 and illustrate the presence of positive staining in 
both the FGR-MNR and AGA-Control animals for each of the liver, kidney and placenta, 
indicating some level of local tissue hypoxia even under normal physiologic conditions in the 
fetus. In the liver, Hypoxyprobe-1 staining was widely seen within the hepatocytes, but the 
percent area of positive cell staining as an index of local tissue hypoxia was increased in the 
FGR-MNR fetuses by ~ 3 fold compared to the AGA-Control fetuses (p<0.05)(Figure 4.4). In 
the kidney, Hypoxyprobe-1 was widely seen within the cortex in the proximal convoluted tubule 
although subjectively less so in the glomerulae, and within the medulla in the distal convoluted 
tubule, but with the percent area of positive cell staining increased in the FGR-MNR fetuses by ~ 
4.5 fold (p<0.01)(Figure 4.4) In the placenta, image analysis was confined to the lobulated 
labyrinth region since this is the largest structural region near term and where nutrient and gas 
exchange primarily occur (Miglino 2004). Hypoxyprobe-1 was again widely seen, and 
subjectively moreso peripherally and less so centrally within the labyrinth lobules. However, in 
contrast to the liver and kidney there was no increase in the percent area of positive cell staining 
for Hypoxyprobe-1 in the placentas of the FGR-MNR fetuses as studied (Figure 4.4).  
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Table 4.1 Overall Fetal Population Characteristics 
 
 Ad Libitum Control Maternal Nutrient Restricted 
Fetal weight (gms) 96±2 69±2*** 
Placental weight (gms) 6.6±0.3 5.1±0.2** 
Placental/fetal weight ratio 0.068±0.003 0.076±0.003* 
Crown rump length (cm) 12.3±0.2 10.6±0.1*** 
Fetal weight/length (gm/cm) 7.8±0.1 6.4±0.1*** 
 
Data presented as means ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs corresponding 
Control group value; n values were 31 and 42 for fetal Control and Maternal Nutrient Restricted 
characteristics, respectively; GA = gestational age. 
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Table 4.2 Select Fetal Population Characteristics 
 AGA-Control FGR-MNR 
Fetal weight (gms) 101±2 64±2*** 
Brain weight (gms) 2.73±0.05 2.39±0.04*** 
Liver weight (gms) 4.7±0.2 2.8±0.1*** 
Brain/liver weight ratio 0.61±0.03 0.90±0.03*** 
Blood glucose (mmol/l) 5.9±0.4 4.3±0.2** 
Blood hemoglobin (gm/dl) 14.6±0.4 15.9±0.2* 
 
Data presented as means ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs corresponding AGA-
Control group value; n values were 20 and 25 for fetal AGA-Control and FGR-MNR 
characteristics, respectively, except for blood glucose and hemoglobin where these were instead 
15 and 19, respectively; AGA = appropriate for gestational age, FGR = fetal growth restricted, 
MNR = maternal nutrient restricted. 
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Figure 4.1 Western blot analysis of EPO from fetal guinea pig liver, kidney and placenta. 
Representative immunoblots (top) of EPO (28 kDa) and ß-actin (42 kDa) from male and female 
AGA-Control and FGR-MNR animals. Density of EPO (bottom) normalized to ß-actin and 
presented as the mean fold change ±SEM for FGR-MNR fetuses (grey bars, n=16) from that of 
the AGA-Control fetuses (open bars, n=16), separated for the male (M) (n= 8 + 8) and female (F) 
(n= 8 + 8) subgroupings. * p<0.05, **p<0.01, ***p<0.001; EPO=erythropoietin; MNR=maternal 
nutrient restriction; AGA=appropriate for gestational age; FGR=fetal growth restriction. 
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Figure 4.2 Western blot analysis of EPOR from fetal guinea pig liver, kidney and placenta.
Representative immunoblots (top)
AGA-Control and FGR-MNR animals. 
presented as the mean fold change ±SEM for FGR
the AGA-Control fetuses (open bars, n=16), separated for the male (M) (n= 8 + 8) and female (F) 
(n= 8 + 8) subgroupings. *p<0.05, **p<0.01; EPOR=erythropoietin receptor; MNR=maternal 
nutrient restriction; AGA=appropriate for gestational age; FGR=fetal growth restriction.
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Figure 4.3 Western blot analysis of VEGF from fetal guinea pig liver, kidney and placenta. 
Representative immunoblots (top) of VEGF (42 kDa) and ß-actin (42 kDa) from male and 
female AGA-Control and FGR-MNR animals. Density of VEGF (bottom) normalized to ß-actin 
and presented as the mean fold change ±SEM for FGR-MNR fetuses (grey bars, n=16) from that 
of the AGA-Control fetuses (open bars, n=16), separated for the male (M) (n= 8 + 8) and female 
(F) (n= 8 + 8) subgroupings. *p<0.05, **p<0.01; VEGF=vascular endothelial growth factor; 
MNR=maternal nutrient restriction; AGA=appropriate for gestational age; FGR=fetal growth 
restriction. 
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Figure 4.5 Hypoxyprobe-1 immunohistochemical staining and quantification in the fetal 
guinea pig. Representative photomicrographs illustrating positively stained cells for 
Hypoxyprobe-1 (brown) in the liver of an AGA-Control (A) and FGR-MNR (B) fetus showing 
the staining to be widely dispersed within the hepatocytes but increased in FGR-MNR fetuses; in 
the renal cortex of an AGA-Control (C) and FGR-MNR (D) fetus showing the staining moreso in 
the proximal convoluted tubule and increased in FGR-MNR fetuses; and in the labyrinthine zone 
of the placenta of an AGA-Control (E) and FGR-MNR (F) fetus showing the staining moreso 
peripherally than centrally within the labyrinthine lobules, but with no difference between FGR-
MNR and AGA-Control fetuses. Sections were also counterstained with hematoxylin. Scale bar 
= 50µm. AGA=appropriate for gestational age; FGR=fetal growth restriction; MNR=maternal 
nutrient restriction. 
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4.4 DISCUSSION 
In the present study, we have examined markers of tissue hypoxia in guinea pig fetuses subjected 
to moderate MNR both before and throughout pregnancy as a useful model for inducing FGR 
with similarities to that seen in humans with maternal undernourishment and idiopathic placental 
insufficiency. As outlined in Chapter 3, and as others (Sohlstrom 1998; Roberts 2001) have 
reported, moderate MNR at 70% of the ad libitum diet beginning at least 4 weeks pre-pregnancy 
and increasing to 90% of the ad libitum diet mid-pregnancy at day 35, results in a decrease in 
fetal weights by 30 to 40% on average for all MNR pregnancies necropsied near term at 60/61 
days gestation. These fetuses have increased placental/fetal weight ratios as also seen in human 
pregnancies leading to FGR both with maternal undernourishment and presumed placental 
insufficiency and taken to indicate a degree of compensatory growth by the placenta to minimize 
FGR (Resnik 2014; Kramer 1987; Abrams 1991). These fetuses also have a decrease in fetal 
weight/length and indicating leaner animals. Likewise, leanness is often a characteristic in 
human infants with moderate growth restriction whether resulting from maternal 
undernourishment or idiopathic placental insufficiency (Godfrey 1998; Kramer 1990; Fall 1999). 
We set a threshold of ≥ 80 gms or < 80 gms for categorizing AGA-Control and FGR-MNR fetal 
cohorts, respectively, which was close to the 10th percentile for the population weight 
distribution of the liveborn Control fetuses at ~ 78 gms. This establishment of AGA-Control and 
FGR-MNR cohort groups has the advantage of avoiding any confounding effects of 
tissue/metabolite study in AGA fetuses from MNR pregnancies and FGR fetuses from Control 
pregnancies and better reflects the human situation where AGA and FGR birth weight 
distributions are separate and often delineated by the 10th percentile adjusted for gestational age 
(Resnik 2014; Lackman 2001). These FGR-MNR fetuses show asymmetrical growth restriction 
with the mean decrease in liver weights much more than that of the brain and heart, and are 
polycythemic and hypoglycemic which are also well associated with moderate growth restriction 
during human pregnancy (Lafeber 1984; Turner 2009; Lackman 2001). Of note, asymmetrical 
FGR and polycythemia and/or hypoglycemia are also seen in guinea pigs with mid-gestation 
uterine artery ligation/ablation (Lafeber 1984; Jansson 1990) and in humans with placental 
insufficiency leading to growth restriction (Soothill 1987; Cox 1988; Economides 1989), with 
both of these likely to involve chronic fetal hypoxemia as a primary signaling mechanism. These 
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findings along with the altered vascular development and structural changes reported in the 
placenta of guinea pigs subjected to moderate MNR (Sohlstrom 1998; Roberts 2001) also raise 
the possibility of chronic hypoxemia as a primary signaling mechanism for the decreased fetal 
growth in these pregnancies. 
Erythropoietin or EPO, is a glycoprotein hormone that binds to its cognate receptor on erythroid 
progenitor cells stimulating their survival and differentiation, with the rate of red blood cell 
production thereby normally determined by blood/tissue EPO levels (Semenza 2009; Eckardt 
2005, Wardrop 1996). EPO synthesis is inversely related to oxygen availability with the main 
determinant the transcriptional activity of its gene by hypoxia-inducible factor 1 in tissues which 
is related to local oxygen tensions (Eckardt 2005, Wardrop 199641,42). During fetal 
development, EPO synthesis gradually changes from hepatocytes stimulating erythropoiesis in 
the liver in a paracrine manner, to renal EPO-producing cells in the cortex and outer medulla 
stimulating erythropoiesis in the bone marrow in an endocrine manner, with the timing for this 
transition species dependent (Wardrop 1996; Teramo 2009; Kowalska-Kańka 2013; Suzuki 
2015) 42-45). However, secretion of small amounts of EPO have also been identified in other 
fetal tissues and for the placenta this can become substantial in response to fetal hypoxemia 
(Teramo 2009; Kowalska-Kańka 2013). Cord blood/amniotic fluid EPO levels and 
erythroblastosis have been well studied in high-risk pregnancies where fetal hypoxemia is 
suspected including FGR, and shown to be increased as an adaptive response and variably 
relating to the degree of hypoxemia (Teramo 2009; Snijders 1993) 43,44,46). In the present 
study, the female FGR-MNR fetuses exhibited increased EPO levels in the three tissues studied, 
namely the liver, kidney and placenta. To our knowledge this is the first study of tissue EPO 
levels in the guinea pig fetus and indicates that all three of these tissues contribute to the 
production of EPO near term. Moreover, the increase in EPO levels as a measure of related gene 
activity is in keeping with a degree of local hypoxia in these tissues supporting our conjecture of 
relative fetal hypoxemia in FGR-MNR fetuses. Surprisingly, this increase in EPO levels was 
confined to the female FGR-MNR fetuses where tissue levels were similarly increased ~ 2 fold, 
while that for the male FGR-MNR fetuses showed little change, although both males and 
females showed similar increases in their hemoglobin values. Mechanisms underlying these 
differences are not readily apparent and Clemons et al. found no sexual dimorphism in the EPO 
response of fetal and neonatal rats to induced hypoxia (Clemons 1986). However, there are 
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known to be sex-related differences in physiologic responses to hypoxia with females showing 
better adaptation to hypoxia than males, which includes the ventilatory and erythropoietic system 
responses to hypoxia which are tightly linked in females but not in males (Soliz 2012 48). 
Additionally, the kinetics of EPO synthesis are relatively insensitive to the degree of hypoxia due 
to the “sigmoidal-like” binding curve by the sensor for O2, and the complex relationship 
between blood PO2 and tissue PO2 which is dependent on a number of factors including blood 
flow distribution, blood volume, hemoglobin concentration, hemoglobin-O2 affinity, and O2 
consumption (Wardrop 1996 42). While these different physiologic processes are interrelated, 
they result in individual variation in the relationship between EPO synthesis, tissue oxygenation 
and hemoglobin levels, which could also have a sex-related bias contributing to the present EPO 
findings.  
EPOR is a cell surface transmembrane protein to which EPO must bind in order to achieve signal 
transduction in both erythroid and non-erythroid tissues (Beleslin-Cokic 2004; David 2006). As 
such, EPOR is found in both the liver and bone marrow during fetal development in relation to 
the ontogeny for erythropoiesis (David 2006; David 2002). However, EPO has also been 
reported to have non-hematologic functions including the promotion of angiogenesis and cellular 
proliferation/differentiation, as well as cytoprotection (Beleslin-Cokic 2004; Kowalska-Kańka 
2013 44,49). Accordingly, EPOR has been found in other fetal tissues including the kidney and 
placenta (Kowalska-Kańka 2013; David 200244,51). While the signaling for EPOR expression 
in tissues may variably involve HIF-1, nitric oxide, or even EPO itself, a primary stimulus for all 
of these will still be tissue hypoxia (Beleslin-Cokic 2004; Cokic 2014). Similar to the EPO 
findings, EPOR levels were increased ~ 1.5 fold in female FGR-MNR liver tissues compared to 
that of the female AGA-Controls consistent with some degree of local hypoxic stimulus and the 
adaptive need for increased erythropoiesis. However, there was no evident change in EPOR 
levels in the kidney or placenta for either the male or female FGR-MNR fetuses suggesting that 
non-hematologic EPO-EPOR responses to not occur with chronic hypoxemia, at least for the 
kidney and placenta. Surprisingly, EPOR levels were actually decreased in the male FGR-MNR 
liver tissues indicating sexual dimorphism in this response which may relate to the same issues 
discussed for the dimorphic EPO response or possibly a direct facilitative/inhibitory impact of 
sex hormones on this response.  
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Vascular endothelial growth factor or VEGF includes a family of glycoprotein hormones of 
which VEGF-A is the most abundant, which bind to cognate receptors on endothelial progenitor 
and mesenchymal stem cells and on vascular endothelial and smooth muscle cells, thereby 
stimulating vasculogenesis and angiogenesis (Semenza 2009; Rehn 2014,53). As such, VEGF 
plays a prominent role during fetal development as a major regulator of vascular development 
and has been reported on in several fetal tissues including the liver, kidney and placenta (Rehn 
2013; Baserga 2009; Rehn 201453-55). Although the expression of VEGF is influenced by 
several factors including other growth factors, transcriptional factors and steroidogenic activity, a 
major stimulus for the upregulation of VEGF is local tissue hypoxia mediated by HIF-1 
(Semenza 2009; Rehn 2014; Shwelki 1993; Trollmann 2003)29,53,56,57). Similar to the EPO 
and EPOR findings, VEGF levels were increased in female FGR-MNR liver tissues compared to 
that of the female AGA-Controls and again consistent with some degree of local hypoxic 
stimulus. However, VEGF levels in the kidney and placenta of the female FGR-MNR fetuses 
remained unchanged suggesting that the increased liver values might somehow relate to 
increased erythropoiesis here, rather than as an angiogenic stimulus. It is thus of note that in mice 
erythropoiesis in the fetal liver is impaired when hypoxic induction of VEGF is lacking and 
indicating a role for VEGF with erythropoiesis in the fetal liver (Rehn 2014). The unchanged 
VEGF levels in the liver and kidney of the male FGR-MNR fetuses likewise support a VEGF-
erythropoiesis linkage rather than an angiogenic linkage. Here, the absence of change in the liver 
might be due to an earlier transition in erythropoeisis from the liver to the bone marrow in FGR 
males which might also explain the lower EPOR levels seen here. However, VEGF levels were 
increased more than two-fold in male FGR-MNR placentas and likely now as an angiogenic 
response to tissue hypoxia. While the mechanisms underlying this differential response from that 
of the female FGR-MNR fetuses remain to be determined, altered vascular development and 
increased VEGF expression are well described in human FGR placentas where chronic 
hypoxemia is known to be a contributing factor (Economides 1989; Trollmann 2003; Bosco 
2010).  
Pimonidazole, a 2-nitroimidazole compound, is reduced at low oxygen concentrations forming 
covalent protein adducts and binding to thiol-containing molecules that can then be detected 
immunohistochemically as markers for intracellular hypoxia (Raleigh 1999; Lee 2001). 
Accordingly, Hypoxyprobe-1 or pimonidazole hydrochloride and associated antibodies that bind 
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to pimonidazole adducts in hypoxic tissues, has been widely used as a hypoxia marker including 
study in fetal and placental tissues (Oh 2008; Kulandavelu 2013; Schaffer 2006  59-61). In the 
present study, Hypoxyprobe-1 staining was seen in the AGA-Control animals for each of the 
liver, kidney and placenta, indicating some level of local tissue hypoxia even under normal 
physiologic conditions in the fetus which was also noted by Oh et al. in near term fetal guinea 
pigs (Oh 2008). This is to be expected as oxygen consumption in cells close to blood vessels 
creates oxygen gradients for more distal cells, which is then amplified by the lower partial 
pressure for oxygen normally seen during fetal development. Hypoxyprobe-1 staining in the liver 
was widely seen within the hepatocytes, while in the kidney this was subjectively less in the 
glomeruli than the surrounding proximal convoluted tubule area. This is consistent with renal 
blood flow initially to the glomeruli and thereby better oxygenation, prior to passing through the 
surrounding cortical tissue as reported for the adult kidney (Suzuki 2015).  Hypoxyprobe-1 was 
substantially increased in both the liver and kidney tissues of the female FGR-MNR fetuses 
indicating lower levels of oxygenation in these tissues relative to that of the female AGA-Control 
fetuses. Of note, chronic exposure to lower environmental oxygen in pregnant guinea pigs and 
leading to FGR, has also been shown to increase Hypoxyprobe-1 staining in fetal livers 
attributable to relative tissue hypoxia (Oh 2008). Hypoxyprobe-1 staining in the placenta was 
again widely seen, but subjectively moreso peripherally and less so centrally within the labyrinth 
lobules. This is then consistent with the countercurrent blood flow described for the guinea pig 
placenta whereby maternal blood flows from arterial channels at the centre of the lobule to 
venous channels in the interlobium, while fetal blood flows from fetal arteries in the interlobium 
to fetal veins at the center of the lobule, with the centre lobule tissue thereby better oxygenated 
(Miglino 2004). Despite the substantial increases in Hypoxyprobe-1 staining in the liver and 
kidney of the FGR-MNR fetuses, there was no evident change in the placental tissues of these 
animals. Since utero-placental blood flow supplies oxygen to the placenta prior to the fetus, 
placental tissue will normally be better oxygenated than fetal tissue (Kingdom 1997). This may 
be further exaggerated under hypoxic conditions by nitric-oxide mediated vasodilation within the 
placenta`s central region as a mechanism to maintain oxygen homeostasis, albeit at the expense 
of fetal oxygenation (Kulandavelu 2013; Schaffer 2006 61,62). As such, it is likely that tissue 
PO2 values in the FGR-MNR placentas were either unchanged or not lowered sufficiently for 
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differences to be detectable using Hypoxyprobe-1 where marked increases in staining are only 
seen with PO2 values < 10 mmHg (Raleigh 1999; Lee 2001).  
The present study examined the impact of MNR on FGR and the resulting levels of tissue 
hypoxia in FGR-MNR guinea pigs.  There was a significant increase in the amount of HP-1 
immunostaining as a direct measure of lowered oxygen in FGR-MNR fetuses compared to their 
AGA-CTL counterparts in the fetal kidney and liver. Additionally, FGR-MNR animals showed a 
significant increase in EPO protein levels across all three tissues examined. Together, these 
findings suggest that FGR resulting from MNR leads to a degree of hypoxia in the guinea pig 
fetus. Furthermore, the fetal liver also displayed a significant increase in EPOR and VEGF 
protein levels, suggesting an increase in erythropoetic and angiogenic factors resulting from 
blood redistribution, and suggesting that the liver may be undergoing the most adaptive and 
protective mechanisms to allow for proper function in the postnatal environment. These results 
may be explained in part by a greater degree of growth restriction in the liver and therefore a 
greater compensation by the fetus to redirect blood flow to increase nutrient exchange. Many of 
these changes were seen in a sex dependent manner, with females showing greater increases than 
males, therefore underlying mechanisms of these differences have not been fully investigated. It 
should be of continuing interest to examine why females and males undergo different degrees of 
response with respect to MNR and chronic hypoxia. In keeping with an increase hemoglobin 
levels, this provides further evidence for altered oxygen distribution due to maternal 
undernourishment. Overall, these findings implicate chronic hypoxia as a mediator of growth 
restriction and altered development arising from MNR.  
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MATERNAL NUTRIENT RESTRICTION IN GUINEA PIGS ALTERS OXIDATIVE 
STRESS AND AN ANTIOXIDANT RESPONSE 
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5.1 INTRODUCTION 
A variety of maternal, placental, and fetal factors can lead to fetal growth restriction (FGR), 
where fetuses do not meet their full growth-potential.  Placental insufficiency is the major cause 
of FGR in developed countries (Jansson 2007). In these cases, aberrant placental vascularization 
results in fetal hypoxemia, which signals the fetus to restrict its growth in response to the 
decreased nutrient transport (Ferrazzi 2000; Cox 1988). This resulted in many animal models 
that mimic the human FGR condition, using a variety of methodology, including uterine artery 
ligation (UAL), placental embolization, or hypoxia, which all decrease the transport of oxygen to 
the fetus (Kingdom 1997; Jansson 1986). Furthermore, animal models and human cases of FGR 
have elevated makers of oxidative stress in both fetal and placental tissues (Hracsko 2008; Oh 
2008; Evans 2012), which may trigger fetal programming (Luo 2006; Thompson 2012). 
Although these animal models mimic several of the physiological parameters of human FGR 
with placental insufficiency, they insult pregnancy with a one time, acute stressor, which 
prevents the direct translation to the human condition of placental insufficiency seen constant 
throughout pregnancy,  
 
Maternal undernutrition plays a more prominent role in FGR pregnancies in developing countries 
(Walker 2007). Maternal nutrient restriction (MNR) pregnancies show similar 
pathophysiological characteristics as placental insufficiency and hypoxic pregnancies, such as 
decreased placental vascularization and decreased oxygen transport (Redmer 2004). Although 
not as extensively studied as other FGR animal models, MNR animal models may offer more 
insight into chronic gestational insults that cannot be extrapolated from acute hypoxia or blood 
flow occlusion models since MNR is a chronic in utero stress similar to that with placental 
insufficiency. Studies in guinea pigs have already shown the adverse effects of MNR on 
placental development leading to “placental insufficiency” (Roberts 2001), and recently, as 
described in Chapters 3 and 4, MNR gives rise to severe asymmetrical FGR (aFGR) with brain 
and heart sparing, and fetal and placental tissues show evidence for chronic hypoxia. Together 
these results implicate fetal hypoxemia as a further mechanism of injury from maternal 
undernourishment. Of interest, Roberts (2001) reported placentas with reduced surface area, 
increased barrier thickness, and aberrant vascular development in pregnant guinea pigs subject to 
a restricted diet. This has led to the hypothesis that the delivery of nutrients in these 
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underdeveloped placentas is decreased as a function of the smaller area for substrate exchange 
along with the increased diffusional distance. Moreover, human cases of MNR-induced FGR 
have reported an increase in markers of oxidative stress. In particular, Gupta et al.. (2004) 
showed increased oxidative stress in FGR fetuses born to undernourished mothers through the 
measure of superoxide dismutase, catalase, glutathione (GSH), and malondialdehyde (MDA) in 
cord blood. The main objective of this study focuses on the unknown effects of MNR on markers 
of oxidative stress in FGR fetuses.  
 
Previously, hypoxic and blood occlusion animal models resulting in FGR have demonstrated that 
FGR fetuses become hypoxemic and undergo significant oxidative stress due to decreased 
oxygen transport from the placenta. In particular, prenatal hypoxia in pregnant guinea pigs leads 
to increases in MDA, total GSH, and ϒ-glutamyl cysteine synthetase (γ-GCS) (Hasimoto 2012; 
Oh 2008). Further, clinical studies have collected placental and cord blood and determined that 
fetal hypoxemia and oxidative stress are present in FGR pregnancies (Hracsko 2008; Gupta 
2004). The present study will use GSH/GSSG and MDA as markers of oxidative stress in the 
MNR guinea pig model to assess both the antioxidant state of the cell and the subsequent 
oxidative stress-induced lipid damage. To further understand the extent to which oxidative stress 
is occurring as a result of MNR in the fetal guinea pig, this study will assess peroxiredoxin 
antioxidant levels and would expect them to be increased in the FGR-MNR animals compared to 
their AGA-CTL counterparts. 
 
The guinea pig has been frequently used as an animal model to study human pregnancy and the 
pathophysiological effects of gestational stress. The guinea pig is subject to a longer gestation 
(68 days) than other rodents, which allows for a more thorough examination of chronic in utero 
stresses (Dyson 2012). It also possesses a placenta similar to the human’s placenta in terms of 
the single layer of trophoblasts that separate maternal and fetal blood (Roberts 2001). Lastly, 
similar to human perinatal brain development, guinea pigs are prenatal developers born with full 
brain function. This is in contrast to other post-natal developer rodents, whose central nervous 
system development reaches completion postpartum (Dyson 2012). This distinction is important 
in studying the effects of fetal development in response to gestational insults, such as MNR and 
oxidative stress.  
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Following these findings, it is of importance to determine if the MNR guinea pig model also 
demonstrates similar increases in markers of oxidative stress, further validating the MNR model 
as an indicator of placental insufficiency seen with human FGR. The present study tested the 
hypothesis that MNR in near term fetal guinea pigs will result in tissue specific oxidative stress 
as a mechanism for damage from MNR induced placental insufficiency, with an increase in 
oxidative stress makers and antioxidant levels, compared to AGA (appropriate for gestational 
age)-CTL animals. Identifying MNR induces oxidative stress in a tissue-specific manner will 
further our understanding of fetal development and associated organ-specific sparing effects that 
occur during FGR. This will also underline the importance of developing preventative 
antioxidant treatments for identified MNR/FGR human pregnancies.  
 
5.2 MATERIALS AND METHODS 
5.2.1 Animals Cohorts and Tissue Collection 
Guinea pig sows were subjected to either the control or MNR diet regime as outlined in Chapter 
3. At 60 days gestation pregnant guinea pigs underwent a laproectomy as previously described in 
Chapter 3. The fetuses were delivered and body weight and placental weights were obtained for 
all fetuses. All fetuses that met weight characteristics as previously described (Chapter 3) 
underwent a full necropsy, where sections from liver, kidney and placenta tissues were both 
fixed in 4% paraformaldehyde and frozen in liquid nitrogen. During necropsies, guinea pig sex 
was determined by anatomical analysis of the reproductive organs, for presence or absence of 
testis. 
Briefly, and as extensively outlined in Chapter 3, select animals were chosen for protein and 
histological analysis based on sex and position in the uterine horn, in order to be consistent for 
growth factors related to position in horn.  In this study, 16 AGA-CTL animals (8 males and 8 
females) that were from either the first or second medial position in the uterine horn and 16 
FGR-MNR animals (8 males and 8 females) that were from the first or second most medial 
position in the horn were used. For all subsequent analysis, AGA-CTL males were compared 
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only to FGR-MNR males and similar analysis was performed for female fetuses. Tissues were 
stored in -80⁰C freezer until used for glutathione, malondialdehyde and western blot analysis.  
 
5.2.2 Quantification of Glutathione  
Placenta, along with fetal liver and kidney total GSH and oxidized GSSG were measured using a 
commercially available colorimetric assay kit (Cayman Chemical Company, MI). Frozen tissue 
samples were homogenized with 10 mL cold buffer per gm of tissue (50mM MES, 1mM EDTA, 
pH 6.7). Samples were then centrifuged at 10 000g for 15 minutes at 4⁰C and supernatant 
separated in two two aliquots; one for protein quantification and the other for deproteniziation 
and GSH/GSSG measurement. Protein concentrations were quantified for each sample using a 
BCA protein assay kit (Pierce Crop, WI).  
Supernatant to be deproteinzied was mixed with equal volumes of metaphosphoric acid (5g /50 
ml water) then centrifuged at 2000g for 3 minutes. Resulting supernatant was exctracted and was 
frozen at -20⁰C  until ready for GSH quantification. For total GSH analysis, all samples were 
diluted to 20x in MES buffer. For GSSG quantification, liver samples were diluted to 20x and 
kidney and liver samples were diluted 11x in MES. All samples were prepared with 50 µl 
triethanolamine reagent (531 µl triethanolamine and 469 µl water) per ml of supernatant. AGA-
CTL and FGR-MNR males and females were plated in duplicates on a single 96-well plate and 
measured at 405 nm wavelength.  
To exclusively measure just the oxidized form of GSH (GSSG), 10 µl of 1M 2-vinylpyridine 
solution per ml of sample was added to each well. Samples were incubated in the dark at room 
temperature for 60 minutes prior to colorimetric quantification. GSH was calculated by taking 
GSSG from the total GSH. Reduced GSH and oxidized GSSG levels were normalized to protein 
concentrations. Data is presented as total mg for total GSH and as a ratio of reduced 
GSH/oxidized GSSG.  
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5.2.3 Quantification of Malondialdehyde 
Extracted frozen guinea pig placentas and fetal liver and kidney tissues were homogenized with 
10 µL per mg tissue (placenta and kidney) or 15µL per mg tissue (liver) RIPA buffer (50mM 
Tris-HCL, pH 7.4, 150 mM NaCl, 1mM EDTA, 1% Nonidet P40, 0.25% C24H39Na04, 
supplemented with 1mM NaV, 50mM NaF, and 25nM C3H7O6PNa2.XH2O) in the presence of 
an added protease inhibitor (Roche, Mississauga, Ontario, Canada). Homogenized samples were 
sonicated and then centrifuged at 10 000g for 20 minutes at 4⁰C . Supernatant was extracted and 
stored at -20 C until quantification.  
Quantification of MDA was carried out using the commercially available thiobarbituric acid 
reactive substances (TBARS) assay (Cayman Chemical Company, Ann Arbor, MI), and was 
plated in duplicate. All samples were normalized to mg protein (as previously described by BCA 
protein assay). Samples and MDA standards were heated with colour reagents (thiobarbituric 
acid, acetic acid, and sodium hydroxide) and sodium dodecyl sulfate in boiling water for 60 
minutes, removed and immediately placed on ice for 10 seconds, centrifuged and pipetted into a 
96 well plate. MDA levels were measured at 530 nm. 
 
5.2.4 Peroxiredoxin Protein Analysis  
The extracted protein samples from the fetal and placental tissues were used to prepare loading 
samples along with NuPAGE SDS Sample Buffer (4x), Reducing Agent (10x), and dionized 
water. These samples were heated at 70⁰C for 10 minutes to allow for protein denaturation. Gel 
electrophoresis at a voltage of 180V was used to fractionate proteins in NuPage, 4-12% gradient 
polyacrylamide gels (Invitrogen Life Technologies Co., Burlington ON, Canada) for 1 hour. This 
was followed by a gel transfer onto polyvinyliden difuoride membrane (Millipore, Etobicoe, ON, 
Canada) at a voltage of 100V for 2 hours.  
Immunoblotting was performed using primary antibodies specific peroxiredoxin 1 (1:2000; (Lab-
Frontier, Seoul, Korea) and diluted in TBST buffer. Blots were subsequently probed with 
secondary antibody Horseradish peroxidase conjugated donkey anti-rabbit IgG (1:10000, 
Jackson ImmunoResearch Laboratories, West Grove, PA), diluted in 5% milk. Immunoreactive 
98 
 
bands were visualized using an Luminata Forte Western HRP enhanced chemilumnesnsece 
detection system (Thermo Scientific, MA, USA) and VersaDoc Imaging System (BioRad 
Laboratories, Mississauga, ON, Canada). Densitometry analysis of bands was performed using 
ImageLab, with signal saturation software (BioRad Laboratories) and normalized to the protein 
levels of β-actin as a loading control.  
 
5.2.5 Data Acquisition and Statistical Analysis 
Data is reported as mean ± standard error of the mean (SEM). Western blot and population data 
was analyzed using Student’s T-test. Oxidative stress marker data was analysed using 2-way 
ANOVA followed by Tukey’s HSD post-hoc test (p < 0.05) to compare means within groups. 
All statistical analysis was run using Graphpad Prism software (Graphpad Software, California, 
USA).  
 
5.3 RESULTS 
5.3.1 Impaired Fetal Growth Measures and Organ Development 
As outlined in Chapter 4, and shown in Table 4.1, MNR resulted in a significant decrease in 
maternal (p<0.01) and fetal weight (p<0.001) at necropsy. MNR fetuses were 28% lighter 
(96±2.3 g) than control fetuses (69.1±2.3 g). Placental weight also decreased significantly in 
response to MNR (p<0.01), but relative placental/fetal weight was increased significantly in 
MNR pups (p<0.05). Ponderal index increased significantly in MNR fetuses (p<0.01), indicating 
increased leanness as a measure of weight/height3.  
As outlined in Chapter 4, and shown in Table 4.2, both fetal brain (2.73±0.05 vs. 2.39±0.04 g) 
and liver weight (4.79±0.24 vs. 2.80±0.14 g; AGA-control vs. FGR-MNR respectively) 
decreased significantly in select FGR-MNR offspring (p<0.001). Brain/liver weight increased in 
FGR-MNR offspring (p<0.001) which indicates brain-sparing as a measure blood flow 
redistribution. FGR-MNR offspring also had significantly lower blood glucose levels (5.9±0.4 
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vs. 4.2±0.2 mmol/L; AGA-Control vs. FGR-MNR respectively) and had significantly elevated 
hemoglobin and lactate content (p<0.01). Together, these results indicate FGR-MNR fetuses 
underwent asymmetric FGR, were hypoglycemic, and hypoxemic.  
 
5.3.2 Markers of Oxidative Stress and Antioxidants   
There were no significant changes in total glutathione content between groups, (Figure 5.1) 
although there was an overall trend for decreased glutathione content in the liver, kidney and 
placenta in FGR-MNR fetuses compared to AGA-CTL. Figure 5.2 shows the effect of MNR on 
fetal liver and placental GSH/GSSG ratio. Diet had a significant effect on both liver and 
placental GSH/GSSG ratio (p<0.01). When controlling for sex, only FGR-MNR female liver and 
FGR-MNR male placental GSH/GSSG ratio increased significantly (p<0.01). Two-way ANOVA 
further pointed to a significant interaction (p<0.05) between sex and diet on placental 
GSSG/GSH.   
Figure 5.3 shows the significant effect of both diet (p<0.001) and sex (p<0.0001) on liver MDA 
content which was not significant in the placenta (diet p=0.06). Tukey’s HSD Post-hoc analysis 
demonstrated significantly reduced MDA in the female FGR-MNR offspring only (p<0.001).  
PRDX protein levels from Western Blot analysis are displayed in Figure 5.4, There was a 
significant increase in both male (p<0.05) (A) and female (p<0.001) (B) FGR-MNR PRDX 
protein levels in the liver, by 93% and 192%, respectively, as compared to AGA-CTL fetuses.  
There were no significant changes in the kidney or placenta PRDX protein levels. 
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Figure 5.1 MNR does not influence total Glutathione Content.  Total glutathione content for 
AGA-CTL males and females; and FGR-MNR males and females. N=8 in each group. Data 
presented as mean glutathione ± SEM. Data between MNR and Control groups was analyzed 
using 2-way ANOVA, followed by Tukey’s HSD test. Fetal kidney, liver, and placenta all had 
decreased GSH, although it was not significant in any tissue.  
. 
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Figure 5.2 MNR selectively increases the ratio of the reduced form of glutathione (GSH) 
compared to oxidized glutathione (GSSG).  Ratio of GSH/GSSG for AGA-CTL and FGR-
MNR fetuses, both males and females. N=8 in each group. Data presented as mean GSH/GSSG 
± SEM. Data between MNR and Control groups was analyzed using 2-way ANOVA, followed by 
Tukey’s HSD test. FGR-MNR fetal kidney, liver, and placenta all had increased GSH/GSSG, 
although only significant in the female liver, and male placenta compared to AGA-CTL fetuses.  
** Denotes significant difference between groups, P<0.01.  
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Figure 5.3 MNR decreases malondialdehye content as a maker of lipid peroxidation in the 
fetal guinea pig.  Total malondialdehyde content (µmol/mgprotein) for AGA-CTL and FGR-
MNR fetuses, both males and females. N=8 in each group. Data presented as mean 
malondialdehyde content (µmol/mgprotein ± SEM. Data between MNR and Control groups was 
analyzed using 2-way ANOVA, followed by Tukey’s HSD test. FGR-MNR fetal kidney, liver, and 
placenta all had decreased malondialdehyde in both sexes, and it was significant in all tissues 
with the exception of the MNR-female placenta.  
* Denotes significant difference between groups, P<0.05.  
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Figure 5.4 MNR results in increased liver PRDX protein in the fetal guinea pig.  
Peroxiredoxin protein levels (normalized to B-Actin protein for each sample) for AGA-CTL and 
FGR-MNR fetuses, both males and females. N=8 in each group. Data presented as mean fold 
change from AGA-CTL groups ± SEM. Data between MNR and Control groups was analyzed 
by Western Blot using Student’s T-Test. FGR-MNR fetal liver had significantly increased PRDX 
protein in both the male and female groups, compared to their AGA-CTL counterparts.  
* Denotes significant difference between groups, P<0.05.  
*** Denotes significant difference between groups, P<0.001. 
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5.4 DISCUSSION 
Fetal growth restriction and oxidative stress during fetal development both contribute to long 
lasting and severe adverse consequences on post-natal health and are at increased risk for adult 
disease (Biri 2007; Takagi 2004; Thompson 2012). As previously described in Chapter 3, MNR 
prior to and continuing throughout pregnancy results in fetuses that are not only smaller in size, 
but upon further characterization of these FGR-MNR cohort, the growth restriction found was of 
the vital organ sparing, asymmetrical variety. This finding is consistent with FGR resulting from 
placental insufficiency where the brain to liver weight ratio is significantly increased in FGR 
fetuses. These findings indicate brain-sparing and hepatic underdevelopment that is similar to 
that seen with human cases placental insufficiency and chronic hypoxia (Haugen 2005).  
The most pertinent finding in this study was the significant increase in the antioxidant 
peroxiredoxin in FGR-MNR fetuses as it may indicate that a protective response mechanism has 
been triggered due lowered oxygen. PRDX acts as a defense against oxidative stress by removal 
of harmful hydrogen peroxide (Rhee 2005). The increase in PRDX protein levels in FGR-MNR 
fetuses may indicate that an antioxidant response has been triggered by increased cellular stress 
due to a build-up of ROS from MNR (Burton 2004; Cumming 2007; Rhee 2005). The increases 
were limited to the male and female liver FGR-MNR fetuses, which add the findings of Chapters 
3 and 4 that the liver is undergoing extensive adaptations due to undernourishment. The 
increased PRDX combined with a decrease in MDA and GSH/GSSG may suggest an oxidative 
stress insult has already occurred early on in gestation, perhaps at the onset of improper placental 
development resulting from MNR, and in turn, the antioxidant levels have increased to further 
protect the fetus from ROS damage (Burton 2004). These findings also suggest a protective role 
as PRDX was increased in the organ that was most susciptile to growth restriction and hypoxia 
as outlined in Chapters 3 and 4.   
In conjunction with increased antioxidant activity, the main goal of this study was to assess the 
levels of oxidative stress markers resulting from MNR during pregnancy. The ratio of reduced to 
oxidized glutathione is used as a marker of the redox state of a cell and cellular toxicity (Pastore 
2003). A decrease in GSH/GSSG relative to physiological normal is considered indicative of 
oxidative stress (Halprin 1967). In this study, both total and GSH/GSSG ratio was assessed. The 
most surprising finding of this study was a significant increase in GSH/GSSG ratio in the male 
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placenta and female liver. These results are contrary to other animal models whereby 
environmental hypoxia resulted in increased glutathione content in fetal tissues (Hashimoto 
2012; Oh 2008). Given that these animals do show evidence for chronic hypoxia resulting from 
placental insufficiently, these counter intuitive results may be the consequence of a variety of 
factors from this MNR study, including the model of nutrient restriction, as well as the time point 
of tissue collection and analysis.  Previous studies have indicated that the total GSH content may 
not be indicative of oxidative stress due to the lack of substrates delivered to the MNR fetuses 
throughout pregnancy resulting from placental insufficiency (Langley-Evans 1995). Considering 
the evidence for increased antioxidants in FGR-MNR animals, the near term fetus may also 
exhibit changes in oxidative stress markers that are markedly different from an early time point 
in gestation. During exposure to an adverse in utero environment, a fetus is able to cater their 
growth to accommodate and defend against such detrimental insults (Calkins 2011; Luo 2006). 
FGR-MNR fetuses were subject to lack of nutrition from the point of conception, and fetal organ 
development was continuously being restricted by the limited nutrient supply arising from 
improper placental growth in a lowered oxygen environment, as discussed in Chapter 3. The 
fetus then adapts and may grow more slowly and conservatively as a survival mechanism, 
reducing substrate demand from an already depleted supply (Roberts 2001). It is possible that 
such adaptations occurred early on in the undernourished fetal life, and an early oxidative stress 
response may have triggered altered metabolic activity to support low nutrient demand. The 
increases in GSH/GSSG ratio also may further illustrate the protective mechanism that occurs in 
the FGR animal during chronic insults. These adaptations would allow for increased resistance to 
cellular oxidative stress and by near term the levels of such oxidative stress markers would be 
lowered. It would be of interest to examine FGR-MNR fetuses at mid-to-early gestation and see 
if the oxidative stress marker differences remain similar. These studies may point to the 
differences seen in the ratio of GSH/GSSG.  
Another pertinent finding was the difference in levels of MDA as a marker of lipid peroxidation, 
which is increased during oxidative stress events (Janero 1990). MNR-FGR fetuses showed 
lower levels of MDA compared to their AGA-CTL counter parts, which again suggests a 
decreased level of lipid peroxidation in these animals. Similarly to GSH, MDA has been 
previously reported to increase in animal and human cases of FGR (Hasimoto 2012; Evans 2012; 
Gupta 2004). This decrease in lipid peroxidation may be partially explained not by an oxidative 
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stress response, but also by the effect of MNR on lipid availability. MNR leads to placental 
insufficiency, which in turn decreases the placentas efficiency in transporting glucose, amino 
acids, and lipids (Belkaceemi 2010). This suggests that the decrease in MDA levels in the FGR-
MNR fetuses may be the result of an overall reduction in lipid content of the liver and the 
placenta. Further studies should aim at assessing lipid content levels in tissues from both control 
and MNR tissues. Additionally, previous studies have linked undernutrition during adult life with 
decreased oxidative stress makers with decreased MDA (Bokov 2004). Together with 
GSH/GSSG, these results point towards a much more impactful role of nutrition itself, rather 
than the resulting placental insufficiency and hypoxia, on fetal levels of oxidative stress markers.  
In addition to differences between the FGR-MNR and AGA-CTL cohorts, differences in males 
and females were also analyzed for both GSH and MDA levels. Although the trends for both the 
liver and placenta were similar in each sex in this study, in the AGA-CTL animals there were 
significant effects of sex in the liver and the placenta in MDA and GSH/GSSG results, 
respectively. Sexual dimorphisms are prevalent in development (Clifton 2010; Muralimanoharan 
2010), and MNR has been previously demonstrated to affect gene expression differently 
dependant on the sex (Guo 2013; Mao 2010). It has also been suggested that male fetuses are 
more sensitive to maternal diet than females (Eriksson 2010). This may be due to a female 
defense mechanism that naturally programmes them to be more resilient to adverse events such 
as MNR, due to the presence of an increase in post-natal stresses such as pregnancy (Valle 
2007). Males also tend to dispense less energy to placental development, and more towards brain 
and heart development, which may also contribute to the differences seen in AGA-CTL animals. 
Together, some of these sex differences could account for the changes in oxidative stress 
markers between males and females.  
In summary, there was a reduced amount of MDA as a measure of lipid peroxidation in FGR-
MNR fetuses compared to their AGA-CTL counterparts. Additionally, FGR-MNR animals 
showed an overall increase in GSH/GSSG ratio as a measure of the redox state of the tissues. 
Both of these results are opposite with previously studied animal models of placental 
insufficiency and a degree of hypoxia. These results may be explained in part by the lack of 
nutrients available due to the model of MNR and therefore may not represent the clearest idea of 
oxidative stress occurring in the near term fetus. However, the increase in PRDX protein levels 
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as a marker of antioxidants and therefore a defensive mechanism against an oxidative stress 
response may also explain these decreases. Due to constant state of nutrient restriction, it is 
likely that an oxidative stress response occurred in these animals at a much earlier time point in 
gestation, and that by the near-term necropsy, these FGR-MNR fetuses were already combating 
the stresses by deploying antioxidant which may contribute to the overall decrease in oxidative 
stress at near-term. This antioxidant response, in combination with the nutritional effects, helps 
to identify important underlying mechanisms behind improper maternal nutrition and the 
oxidative stress response. 
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6.1 GENERAL DISCUSSION 
Through the advances of the developmental origins of health and disease, the intrauterine 
environment has been of extreme interest to investigators. Through these studies, evidence now 
suggests that sub-optimal growth during gestation, resulting in low birth weight, is associated 
with a number of long-term adverse outcomes, including neurological, cardiovascular, and 
metabolic disabilities. Although many factors contribute to FGR, improper placental growth and 
therefore impaired nutritional transport to the fetus plays a major role in many human cases of 
FGR. Although many animal models use techniques to induce placental insufficiency, this study 
was designed to further characterize how nutrient restriction model would act as a more 
representative model of human aFGR, and determine if there were any changes in oxygenation 
and oxidative stress that occurred because of MNR.  
In recent studies, moderate MNR in guinea pigs has been utilized for modeling human FGR 
including maternal, placental, and fetal growth characteristics. These studies have reported 
associated IGF and IGFBP alterations, giving insight into mechanisms for programming long-
term adverse outcomes in offspring (Sohlstrom 1998; Roberts 2001a; Kind 2003; Kind 2005). 
This study has further characterized this model by adding breeding success and pregnancy 
outcomes in MNR animals as outlined in Chapter 3. This study also exhibited the utility of the 
MNR model to induce FGR, resulting in dramatically lower fetal death rates compared to that 
seen with uterine ligation/ablation models (Lafeber 1984; Turner 2009), although an increased 
preterm delivery was reported as is seen with FGR in humans (Lackman 2001). As previously 
investigated, this study has confirmed that MNR guinea pig fetuses have increased placental/fetal 
weight ratios that are often seen in human cases of FGR. (Kramer 1990; Godfrey 1998; Lumey 
1998; Belkacemi 2010; Lackman 2001; Fall 1999).  
This study provided justification for using a fetal weight threshold of 80 gms for categorizing 
AGA-Control and FGR-MNR cohorts, with 80 gms being representative of the 10th percentile in 
our ad libitum fed animals. An important finding among the FGR-MNR cohort is that fetuses 
show aFGR, and are polycythemic and hypoglycemic which are well associated with moderate 
growth restriction during human pregnancy (Kramer 1990; Resnk 2014; Kramer 1991; Abrams 
1991; Soothill 1987; Cox 1988; Economides1989).  
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These findings, combined with previous work in MNR guinea pigs showing altered vascular 
development and structural changes in the placentas (Roberts 2001a; Roberts 2001b), also make 
it likely that chronic hypoxemia is occurring as a primary signaling mechanism for the decreased 
fetal growth in these pregnancies. As presented in Chapter 4, the impact of MNR on FGR and 
the resulting levels of tissue hypoxia in FGR-MNR guinea pigs were investigated. There was a 
significant increase in HP-1 immunostaining as a direct measure of low oxygen environments in 
female FGR-MNR fetuses in the kidney and liver. HP-1 has been previously used to directly 
confirm hypoxia in the guinea pig fetus (Oh 2008), suggesting that MNR results in decreased 
levels of oxygenation in the growth restricted fetus. Additionally, protein markers of the HIF-1α 
pathway were used to determine changes in response to altered oxygenation. FGR-MNR animals 
showed a significant increase in EPO protein levels across all three tissues examined. 
Furthermore, the fetal liver also displayed a significant increase in EPOR and VEGF protein 
levels, suggesting an increase in erythropoeitic and angiogenic factors resulting from blood 
redistribution. Together these protein levels suggest an adaptive and systematic response to 
lowered oxygenation through the HIF pathway, which has been seen with human cases of FGR 
(Ostlund 2000; Jazaveri 1999). Overall, these findings implicate chronic hypoxia as a mediator 
of growth restriction and altered development arising from MNR. 
Following the changes tissue oxygenation and evidence for chronic hypoxia, this study focused 
on determining if there were also associated changes in oxidative stress and antioxidant markers 
in FGR-MNR animals (Chapter 5).  There was a reduced amount of MDA as a measure of lipid 
peroxidation in FGR-MNR fetuses compared to their AGA-CTL counterparts. Additionally, 
FGR-MNR animals showed an overall increase in GSH/GSSG ratio as a measure of the redox 
state of the tissues. Both of these results are opposite to previously studied animal models of 
placental insufficiency with environmental hypoxia (Hracsko 2008; Oh 2008; Evans 2012; 
Schafer 2001). These results may be explained in part by the lack of nutrients available due to 
the model of MNR and therefore may not represent the clearest idea of oxidative stress occurring 
in the near term fetus. However, the increase in PRDX protein levels as a marker of antioxidants 
and therefore a protective mechanism against oxidative stress due to increased ROS may also 
explain these decreases (Reddy 2008; Neumann 2009). Due to the chronic nature of nutrient 
restriction, it is likely that an oxidative stress response occurred in these animals early in 
gestation, and that by the near-term necropsy, these FGR-MNR fetuses were already combating 
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the stresses by deploying antioxidants which may contribute to the overall decrease in oxidative 
stress at near-term. This antioxidant response, in combination with the nutritional effects, helps 
to identify important underlying mechanisms behind improper maternal nutrition and the 
oxidative stress response.  
Together, the present and past studies of moderate MNR in guinea pigs support the utility of this 
model for inducing FGR with many similarities to that in human FGR whether resulting from 
maternal undernourishment or placental insufficiency. This was the first time to date that 
oxidative stress and hypoxia markers, as mechanisms of damage, have been reported using the 
MNR guinea pig model. While there are undoubtedly differences between the mechanisms 
behind FGR resulting from undernourishment vs. placental insufficiency, this study has 
exhibited the merit of using a translatable chronic perturbation to induce growth restriction. 
These results are similar to that seen with human cases, and provided further insight into the 
mechanisms surrounding developmental programming.  
 
6.2 FUTURE STUDIES 
Based on the current findings, future studies should focus on the long-term outcomes and health 
impact of the maternal undernourishment model. Any behavioural and/or neurological changes 
in the growth restricted fetus could be associated with MNR, and give further insight into the 
mechanisms behind developmental programming and the health of the newborn.  
Defining developmental changes in animal models has been done with a variety of different tests 
that can indicate changes in cognition, learning, memory, and behaviour. Tests such as the open 
field test, the T-arm maze, Morris Water maze, and forced swim test could help to better define 
the extent to which MNR and thus FGR is associated with cognitive changes in the guinea pig. 
Correlating these behavioral characteristics with the severity of FGR resulting from MNR could 
provide useful comprehension into the most impactful and advantageous type of therapy, 
dependant of the duration and severity of undernutrition during gestation 
Historically human FGR has been known to cause cardiovascular issues as well as metabolic 
syndrome. More recently, FGR has been shown to have poor neurodevelopmental and 
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neurological outcomes later in adult life  (Fattal-Valevski 2009; Løhaugen 2013). Specifically, 
cognitive impairment, lack of behavioral and attention skills, and physical or neurological impact 
later in life of fetuses who were born FGR. Brain disorders like attention deficit hyperactive 
disorder, autism, cerebral palsy, and schizophrenia have been directly correlated with the 
severity of FGR (Dahlseng 2014; Haglund 2011; Mallard 1999; StrangKarlsson 2008). Whether 
or not MNR acts as a causative factor and indirect contributor to such brain impairment is 
currently unknown and should be the aim of future investigators.  
Neurological changes in the FGR fetus has been well documented in other animal models of 
placental insufficiency, most notably, uterine artery ligation. Since our study has shown to that 
MNR leads to FGR, with a preference for the aFGR phenotype, it is reasonable to believe that 
there are also some similar changes in the brain that are comparable to the FGR human, as well 
as the UAL animal model. Initiation of myelination, axonal and dendritic growth, 
synaptogenesis, and proliferation of microglia and astrocytes are all examples of developmental 
events that can be disrupted or altered if nutrients and oxygen are not available, such as in a 
growth restricted fetus (Kind 2005) For prenatal brain developers such as guinea pigs, and for 
humans as perinatal brain developers, the most rapid phase of synapse formation and neuronal 
myelination onsets during the latter half of pregnancy (McIntosh 1999). As such, FGR with 
MNR may disrupt synapse formation and neuronal myelination, as they are energy demanding 
growth processes (Jiang 2002), this may lead to alterations in brain development and underlie 
risk for later cognitive impairment and neuropathology. Studies done by Piorkowska et al. have 
shown reduced synapse formation in FGR animals, while aFGR animals maintain hippocampal 
maturation of synapse compared to that of the sFGR animals (Piorkowska 2014). Further 
research should focus on whether these changes seen with the UAL model of FGR are also 
present in this studies MNR model of FGR to elucidate MNR as a mechanism for aberrant 
neurological development. 
During exposure to hypoxic environments, neuronal loss has been reported in developing brain 
cells and results in apoptotic/necrotic cell death dependant on the severity of the insult 
(Falkowski, 2002). In some cases of severe nutritional impairment, it is possible that protective 
compensatory mechanisms may become limited and brain energy levels may be sufficiently 
impacted, resulting in an increase in necrotic cell injury and/or changes in apoptotic regulators 
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(Rocha 2004). A better understanding of the extent to which developmental processes in the 
brain are impacted by FGR with maternal undernourishment will allow for the potential for early 
detection and therapies aimed at mechanistic pathways. 
 
6.3 CONCLUSIONS 
In conclusion, the thesis was focused on determining the relationship between MNR and the 
changes in fetal-placental growth, tissue oxygenation and oxidative stress in the near term guinea 
pig. The major findings of this study were: 
1) MNR leads to aFGR fetuses with high brain to liver weight ratio. 
2) Markers of oxygenation are selectively reduced in the MNR-FGR fetus. 
3) Markers of oxidative stress are decreased with an increase in antioxidant levels in the 
MNR-FGR fetus.  
These studies suggest a significant role in using MNR to induce aFGR in the fetal guinea pig, 
with changes in oxygen distribution and antioxidant capacity. This model may better mimic the 
human condition of FGR as seen with placental insufficiency, and undernutrition during 
pregnancy may lead to long-term development disorders in the newborn.  
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